US20230062395A1 - Intrasaccular inverting braid with highly flexible fill material - Google Patents
Intrasaccular inverting braid with highly flexible fill material Download PDFInfo
- Publication number
- US20230062395A1 US20230062395A1 US17/969,851 US202217969851A US2023062395A1 US 20230062395 A1 US20230062395 A1 US 20230062395A1 US 202217969851 A US202217969851 A US 202217969851A US 2023062395 A1 US2023062395 A1 US 2023062395A1
- Authority
- US
- United States
- Prior art keywords
- braid
- inversion
- aneurysm
- inverted
- sack
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04C—BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
- D04C1/00—Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
- D04C1/06—Braid or lace serving particular purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
Definitions
- the present invention generally relates to medical instruments, and more particularly, to embolic implants for aneurysm therapy.
- Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues.
- Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow.
- Current alternatives to endovascular or other surgical approaches can include intravascularly delivered treatment devices that fill the sac of the aneurysm with embolic material or block the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm.
- Treating certain aneurysm morphology can require ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density. Once implanted, the coils cannot easily be retracted or repositioned. Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, blood flow, or large aneurysm size.
- tubular braided implants have the potential to easily, accurately, and safely treat an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel.
- tubular braided implants are a newer technology, and there is therefore capacity for improved geometries, configurations, delivery systems, etc. for the tubular braided implants.
- a tubular braided implant including a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack.
- the additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks.
- the braid can be made such that the distal end, the braid is made stronger, having a tendency to move toward a predetermined shape when implanted and forming the two nested sacks, and at the proximal end, the braid can be made weaker, having a tendency to flatten and fold in a ribbon shape inside of the sacks.
- the braid can have a variable braid angle along its length such that when positioned for delivery, the braid can have a high braid angle near its distal end and a low braid angle near the proximal end.
- the braid can be heat treated to weaken the braid at the proximal end.
- the implant can include an embolic coil that can loop within the innermost sack.
- An example method for treating an aneurysm can include one or more of the following steps presented in no particular order. The example method can further include additional steps not listed here.
- a substantially tubular braid can be selected that has a first end, a second end, a first portion extending from the first end, and a second portion extending from the second end.
- the substantially tubular braid can be selected such that the braid, when in a single layer cylindrical shape having a uniform circumference along a length from one end of the braid to the other end of the braid, the braid has a smaller braid angle in the second portion of the braid compared to the first portion of the braid.
- the braid can be selected such that, when in the single layer cylindrical shape, the braid has a continuously decreasing braid angle extending from the first portion to the second portion.
- the braid can be delivered through a microcatheter to an aneurysm.
- the braid can be delivered in the single layer tubular shape such that the first end is positioned in the distal direction in relation to the second end.
- the first portion of the braid can be expanded to the aneurysm's wall.
- a proximal inversion can be formed in the braid at the aneurysm's neck.
- An inverted portion of the braid can be expanded to press into the expanded first portion.
- a distal inversion can be formed in the braid at a distal portion of the aneurysm's wall such that the inverted portion of the braid extends between the distal and proximal inversions.
- the braid can be shaped to form a dome near the distal portion of the aneurysm's wall within the inverted portion. Additionally, or alternatively, the braid can be twisted at the distal inversion and the braid can be expanded to form a sack within the inverted portion.
- the second portion of the braid can be positioned within the inverted portion, either directly in contact with the inverted portion, within sacks formed within the inverted portion, or otherwise positioned in the inverted portion.
- the second portion of the braid can be positioned such that the second portion is flattened and looped within the inverted portion.
- An embolic coil can be selected.
- the embolic coil can be positioned such that it is affixed to the second end of the braid.
- the embolic coil can be delivered through the microcatheter to the aneurysm.
- the embolic coil can be positioned within the inverted portion of the implanted braid.
- An example implant can include a tubular braid with two ends that is shapeable to a single layer cylindrical shape having a length measurable from one end to the other end, a substantially uniform circumference along the length, a larger braid angle on a first portion of the braid extending from a first of the two ends, and a smaller braid angel on a second portion of the braid extending from a second of the two ends.
- the braid can have a continuously decreasing braid angle extending from the first portion to the second portion.
- the braid can be sized to be delivered through a microcatheter to an aneurysm.
- the braid can be movable from the single layer cylindrical shape to an implanted shape.
- the first portion can be positioned to appose an aneurysm wall
- an inverted sack can be positioned to press the first portion to the aneurysm wall
- the second portion can be positioned within the inverted sack.
- at least a portion of the second portion of the braid can be looped within the inverted portion.
- the second portion can be positioned to press the inverted portion to the first portion.
- an inner sack can be positioned to press the inverted sack to the first portion, the braid can have an inversion separating the inner sack and the inverted sack, and the braid can be twisted at the inversion.
- the braid can have a dome shape within the inverted sack positioned near a distal portion of the aneurysm's wall.
- the implant can further include an embolic coil affixed to the second end of the braid.
- the braid can be shaped to allow the embolic coil to be positioned within the inverted sack, either in direct contact with the inverted sack, separated from the inverted sack by braid material, or otherwise positioned in the inverted sack.
- Another example implant can include a tubular braid having a first end and a second end.
- the braid can have a predetermined shape having two inversions dividing the braid into three segments: an outer segment extending from the first end to a first inversion of the two inversions, a middle segment extending between the two inversions and at least partially surrounded by the outer segment, and an inner segment extending from the second of the two inversions to the second end and at least partially surrounded by the middle segment.
- the braid can have an abrupt change in braid angle at a position on the inner segment such that a distal portion of the inner segment extending from the second inversion has a higher braid angle than a proximal portion of the inner segment extending from the second end.
- the braid can be movable to an implanted shape sized to be positioned within an aneurysm sac.
- a part of the braid corresponding to the inner segment in the predetermined shape can be collapsed to a ribbon shape and positioned in an inverted sack formed from a part of the braid corresponding to the middle segment in the predetermined shape.
- the braid can be shaped to a single layer cylindrical shape having a substantially uniform circumference between the two ends of the braid, a larger braid angle in a first portion of the braid extending from the first end, and a smaller braid angle in a second portion of the braid extending from the second end.
- the braid can have a continuously decreasing braid angle from the first portion to the second portion.
- the braid can be sized to be delivered through a microcatheter to an aneurysm.
- FIG. 1 is an illustration of an implant having a braid shaped for delivery through a catheter according to aspects of the present invention
- FIG. 2 is an illustration of an implant having a braid in a predetermined shape according to aspects of the present invention
- FIGS. 3 A through 3 I are illustrations of steps of an aneurysm treatment process according to aspects of the present invention.
- FIG. 4 is an illustration of an implant having a braid twisting near a distal inversion according to aspects of the present invention
- FIGS. 5 A through 5 B are illustrations of steps of an aneurysm treatment process according to aspects of the present invention.
- FIG. 6 is an illustration of an implant having a braid and an embolic coil each shaped for delivery through a catheter according to aspects of the present invention
- FIG. 7 is an illustration of an implant having a braid and an embolic coil with the braid in a predetermined shape according to aspects of the present invention
- FIG. 8 is an illustration of an implant having a braid and an embolic coil implanted in an aneurysm according to aspects of the present invention.
- FIG. 9 is a flow diagram listing method steps that can be performed according to aspects of the present invention.
- the aneurysm In known treatments of wide neck aneurysms, the aneurysm is typically treated by placing embolic coils within the aneurysm sac and placing a stent within the parent blood vessel across the aneurysm neck.
- the stent is necessary in many cases to inhibit the embolic coils from entering the parent blood vessel. If embolic coils enter the parent blood vessel, the coils can obstruct the vessel and/or clots can form on the coils within the blood vessel and create an obstruction in the parent blood vessel.
- Braided aneurysm intrasaccular implants can be used to treat wide neck aneurysms without requiring a stent to secure the braided implant at the aneurysm neck.
- the braid can be stiff and resistant to reshaping to an implanted shape that is significantly different than a predetermined shape. It can therefore be challenging, in some cases, to pack the aneurysm with a sufficient braid density to quickly and effectively induce blood stasis within the aneurysm sac. A braid made too soft can compact in shape and cause the aneurysm to recanalize as the implant is no longer sealing the neck of the aneurysm.
- a tubular braided implant can include a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack.
- the additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks.
- An aspect of the present invention is to provide a structure that allows a sufficient amount of additional braid material to be placed into the innermost sack such that the aneurysm clots quickly for an effective treatment.
- tubular and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length.
- tubular structures are generally illustrated herein as having a substantially right cylindrical structure.
- a tubular structure can have a tapered or curved outer surface without departing from the scope of the present invention.
- the braid can be made such that portions of the braid pushed into the aneurysm when the aneurysm has a higher packing density are weaker compared to stiffer portions of the braid that expand to anchor the braid within the aneurysm.
- Stiffness/flexibility of the braid portions can be controlled by braid angle (e.g. picks per inch), strand diameter, number of strands, material of strands, and/or treatment (e.g. heat treatment) to modify strand material properties, etc.
- a stiffer portion can have a higher braid angle, a larger strand diameter, more strands, strands comprising a stiffer material, and/or strands treated to have greater stiffness compared to a weaker portion.
- Stiffer portions of the braid can be positioned near a distal end of the braid when the braid is being delivered through a catheter so that the stiffer portions of the braid exit the catheter and expand to anchor in the aneurysm before the aneurysm is packed.
- Stiffer portions of the braid can be shaped in a predetermined shape by heat setting or other means such that when the stiffer portions, they expand toward the predetermined shape. The tendency of the stiffer portions of the braid to expand toward the predetermined shape can create sufficient force against the aneurysm walls to anchor the braid in the aneurysm sac.
- Weaker portions of the braid can be positioned near the proximal end of the braid when the braid is delivered through the catheter. Portions of the braid which have the most flexibility can be dynamically deformed to loop or nest within the aneurysm, folding within the stiffer, anchoring portions of braid.
- the implant can include an embolic coil that can loop within the innermost sack.
- Examples presented herein generally include a braided implant that can secure within an aneurysm sac and occlude a majority of the aneurysm's neck.
- the implant can include a tubular braid having a stiffer portion and a weaker portion, at least the stiffer portion being set into a predetermined shape, the braid being compressible for delivery through a microcatheter, and the braid being implantable in an implanted position that is based on the geometry of the aneurysm in which the braid is implanted and based at least in part on the predetermined shape.
- An example implant 100 can include a braid 110 that can be shaped into a substantially tubular, single layer shape having a length L measured between each end 112 , 114 and a variable stiffness along the length L. As illustrated, stiffness can be determined at least in part by braid angle ⁇ 1 , ⁇ 2 , ⁇ 3 , ⁇ 4 .
- weaker, more flexible portions of braid are illustrated as having a lower braid angle compared to stronger, stiffer portions of the braid; however, weaker and stiffer portions of the braids can differ in strand diameter, number of strands, material of strands, be treated to have differing stiffness/flexibility, and/or by other means as would be appreciated and understood by a person of ordinary skill in the art.
- example implants comprising braid segments of differing stiffness can include two separate sections joined to form a braid, and the braid need not include the segments of differing stiffness as a contiguous braided tube.
- the braid 110 can have a circumference C that is substantially uniform along the length L.
- the tubular shape can have a central axis A extending along the length of the braid 110 .
- a braid angle ⁇ 1 , ⁇ 2 , ⁇ 3 , ⁇ 4 can be measured by comparing the tangential trajectory of a braid strand to the central axis A as illustrated and as would otherwise be understood by a person of ordinary skill in the art according to the teachings herein.
- the braid can include a number of strands, for example, from about 4 to about 96 strands, each extending from one braid end 112 to the other 114.
- the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ⁇ 20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%.
- the strands can wrap helically around the circumference C.
- the number of strands, angle of strands, diameter of the strands, material of strands, and material properties of strands can all be factors in controlling material properties of the braid 110 , including porosity and flexibility.
- Braid strands can be woven such that about half of the strands wrap in a clockwise helix, the other half wraps in a counterclockwise helix, and the oppositely wrapping strands cross over and under each other in an alternating fashion. Constructed as such, portions of the braid having a higher braid angle can therefore having a higher density of strands compared to portions of the braid having lower braid angle. Higher strand density can result in a denser, stiffer braid portion.
- the strands can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, platinum, nitinol, stainless steel, tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time.
- Some or all of braid 110 can be a multi-filament cylindrical mesh made preferably of nitinol with interwoven platinum filaments for radiopacity or Drawn Filled Tube (DFT) Nitinol with about 10 to about 40% platinum.
- DFT Drawn Filled Tube
- the apertures in the mesh of braid 110 can also create a substantially unitary frame work or mesh.
- the apertures can have variable size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 110 .
- the apertures can provide the braid 110 with flexibility and also assist in the transformation of the braid from the collapsed state to the expanded, deployed state, and vice versa.
- the braid 110 as illustrated in FIG. 1 depicts four braid angles ⁇ 1 , ⁇ 2 , ⁇ 3 , ⁇ 4 that increase as measured from the proximal end 112 of the braid 110 to the distal end 114 with the braid angle ⁇ 4 in the proximal portion 116 of the braid 110 being the smallest, the braid angle ⁇ 3 in the section immediate distal to the proximal portion 116 being larger than the braid angle ⁇ 4 in the proximal portion 116 , the braid angle ⁇ 2 in the next distal section being larger than the angle ⁇ 3 in the section immediately proximal to it, and the braid angle ⁇ 1 in the distal most section 118 of the braid 110 being the largest.
- the braid 110 can include two or more sections having differing braid angles and thereby differing stiffness/flexibility.
- the braid can additionally include a continuous gradient change in braid angle and thereby continuous gradient change in stiffness/flexibility from one braid section to another, for instance the braid angle can change continuously from the proximal portion 116 to the distal portion 118 .
- the implant 100 can be delivered to an aneurysm when the braid 110 is sized to traverse a catheter.
- the braid 110 can be delivered in the single-layer tubular shape as illustrated in FIG. 1 such that one end of the braid 114 is a distal end positioned to exit the catheter before the remainder of the braid 110 and the other end 112 is a proximal end positioned to exit the catheter after the remainder of the braid 110 .
- the braid can be delivered in other shapes that include folds, inversions, and/or multiple layers. Regardless of the delivery shape, the braid 110 can have a distal portion 118 positioned to exit the catheter before the remainder of the braid 110 and a proximal portion 116 positioned to exit the catheter after the remainder of the braid 110 .
- the distal portion 118 can have a high braid angle ⁇ 1 such that the distal portion 118 has sufficient stiffness to anchor the braid 110 within the aneurysm.
- the proximal portion 116 can have a low braid angle ⁇ 4 such that the proximal portion has sufficient flexibility to collapse into an aneurysm sac containing the remainder of braid 110 .
- the implant 100 can further include a detachment feature 150 configured to be detachably attached to an implant delivery system. The detachment feature 150 can be affixed to the braid 110 at the proximal end 112 of the braid 110 .
- FIG. 2 illustrates a braid 110 such as the braid 110 illustrated in FIG. 1 shaped into a predetermined shape.
- the braid 110 can include a memory shape material such as Nitinol, a Nitinol alloy, a polymer memory shape material, or other memory shape material having properties for reshaping as described herein.
- the braid 110 can be set to the predetermined shape by heat setting or other means as appreciated and understood by a person of ordinary skill in the art.
- the braided segment 110 can be collapsed from the predetermined shape to a deformed shape sized to traverse a microcatheter to an aneurysm. Upon contact with blood when exiting the microcatheter, the braid 110 can move from the deformed shape toward the predetermined shape.
- the anatomy of the aneurysm and treatment site can inhibit the braid 110 from moving to the predetermined shape such that when the braid 110 is deployed, it can take on a deployed shape that is based in part on the predetermined shape and the shape of the anatomy in which the braid is implanted.
- the braid 110 can include two inversions 122 , 124 and a pinch point 126 dividing the braid 110 into four segments 142 , 144 , 146 , 130 .
- the braid 110 can have an outer segment 142 extending from the open end 114 of the braid 110 to a first inversion 122 of the two inversions 122 , 124 , a middle segment 144 extending between the two inversions 122 , 124 , an inner segment 146 extending from a second inversion 124 of the two inversions 122 , 124 to the pinch point 126 of the braid 110 , and an elongated section 130 extending from the pinch point 126 to an opposite end 112 of the braid 110 .
- the tubular braid 110 can be substantially radially symmetrical around a central vertical axis y.
- FIG. 2 illustrates a profile of each segment 142 , 144 , 146 , 130 .
- the detachment feature 150 is illustrated as a flat key that can be used with a mechanical implant delivery system (not illustrated).
- Example implant delivery systems are described, for instance, in U.S. Patent Application Publication Numbers 2019/0192162 and 2019/0328398 each incorporated herein by reference as if set for in their entireties herein.
- the key 150 can be visualized radiographically.
- the key 150 can be released from the delivery system, thereby releasing the implant 100 from the delivery system. When the implant is released, the key can remain attached to the implant.
- the tubular braid 110 can be formed into the predetermined shape by first pinching the braid 110 at the pinch point 126 , then inverting the braid outwardly to separate the inner segment 146 from the middle segment 144 with an inversion 124 , then shaping the middle segment 144 over a form to produce the substantially “S” shaped profile illustrated, and finally, inverting the braid 110 outwardly again to separate the middle segment 144 from the outer segment 142 with another inversion 122 .
- the braid can be trimmed at the open end 114 and/or the proximal end 112 .
- the open end 114 can be positioned to encircle the middle segment 144 .
- the open end 114 can positioned within the middle third section of the braid's height as illustrated. Alternatively, the open end 114 can be positioned elsewhere, such as near the distal inversion 124 .
- the outer sack 142 can correspond to the distal portion 118 of the braid 110 as illustrated in FIG. 1 .
- the distal portion 118 can have a substantially uniform braid angle ⁇ 1 along its length when the single layer tubular shape illustrated in FIG. 1
- the braid 110 can have an abrupt braid angle change at the proximal inflection 122 .
- the braid 110 can have a graduated braid angle change through the middle section 144 and inner section 146 .
- the tail 130 can have a braid angle ⁇ 4 that is substantially consistent along the length of the tail 130 .
- the tail 130 can correspond to the proximal portion 116 of the braid 110 in the single layer tubular shape as illustrated in FIG. 1 .
- sections 142 , 144 , 146 distal to the pinch point 126 can have a high braid angle ⁇ 1 that is consistent along the length of those sections 142 , 144 , 146 when the braid 110 is in a single layer tubular shape, the tail section 130 can have a low braid angle ⁇ 4 consistent along its length, and the braid 110 can have an abrupt change in braid angle at the pinch point 126 .
- the tail 130 can be sufficiently flexible such that, when manipulated at an intravascular treatment site, it flattens to a ribbon shape and folds onto itself.
- braid 110 can include an abrupt braid angle change at the proximal inflection 122 , at the distal inflection 124 , at the pinch point 126 , or any combination thereof.
- Strands of the braid 110 at the open end 114 can be free, cut ends; or, alternatively, the strands at the open end 114 be closed, meaning strands within the braid at the open end 114 are attached to each other by glue, weld, etc. or the strands bend back at the open end 114 .
- Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends.
- FIGS. 3 A through 3 I illustrate an implant 100 such as the implant 100 illustrated in FIGS. 1 and/or 2 being implant in an aneurysm 10 via a catheter 20 .
- the size of the catheter 20 can be selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site.
- the catheter 20 can have a total usable length from about 80 centimeters to about 170 centimeters.
- the catheter 20 can have an inner diameter ID of from about 0.015 to about 0.032 inches.
- the outer diameter OD can also range in size and may narrow at either its proximal end or distal end.
- the catheter 20 can be manually operated by the end-user, and at its distal end can be operable, as illustrated, to be positioned at the neck 16 of the aneurysm 10 . While the distal end of the catheter 20 can contain the implant 100 , the distal end can be varied in shape and can curve at an angle.
- FIG. 3 A illustrates the open end 114 of the braid 110 expanding within a sac 12 of the aneurysm 10 to contact walls 14 of the aneurysm 10 .
- the section 142 ′ contacting the aneurysm wall 14 can correspond to the outer 142 section in the predetermined shape illustrated in FIG. 2 and/or the distal, stiffer portion 118 of the braid 110 illustrated in FIG. 1 .
- the implant 100 can be selected for treatment such that the selected implant 100 has an outer segment 142 in the predetermined shape having a circumference greater than the circumference of the aneurysm sac 12 , meaning the section 142 ′ of the braid 110 contacting the aneurysm wall provides a force against the aneurysm wall 14 as it tends to expand to the predetermined shape.
- the implanted shape of the outer section 142 ′ can thereby be smaller in circumference than the predetermined shape of the outer section 142 .
- FIG. 3 B illustrates the braid 110 inverting to form a proximal inversion 122 ′ in the implanted shape.
- the proximal inversion 122 ′ can correspond to the proximal inversion 122 in the predetermined shape.
- FIG. 3 C illustrates the braid 110 expanding within the outer section 142 ′.
- FIG. 3 D illustrates the braid forming an inner sack 144 ′ inside of the outer section 142 ′.
- a distal inversion 124 ′ is illustrated positioned near a distal portion 15 of the aneurysm wall 14 .
- the distal inversion 124 ′ can correspond to a distal inversion 124 of the braid 110 in the predetermined shape.
- the inner sack 144 ′ can correspond to the middle segment 144 in the predetermined shape illustrated in FIG. 2 .
- the inner sack 144 ′ can correspond to the stiff, distal portion 118 of the braid 110 illustrated in FIG. 1 and/or a portion of the braid 110 having less stiffness than the distal portion 118 .
- the inner sack 144 ′ can correspond to a portion of the braid 110 having greater stiffness than the flexible proximal portion 116 illustrated in FIG. 1 .
- FIG. 3 E illustrates a collapsible portion 146 ′ of the braid 110 further exiting the catheter 20 and expanding within the inner sack 144 ′.
- the collapsible portion 146 ′ can correspond to the inner segment 146 of the braid 110 in the predetermined shape.
- the collapsible portion 146 ′ can correspond to the stiff, distal portion 118 of the braid 110 illustrated in FIG. 1 and/or a portion of the braid 110 having less stiffness than the distal portion.
- the collapsible portion 146 ′ can correspond to a portion of the braid 110 having greater stiffness than the flexible proximal portion 116 illustrated in FIG. 1 .
- FIG. 3 F illustrates the collapsible portion 146 ′ forming a dome near the distal inversion 124 ′.
- a pinch point 126 ′ is illustrated on the proximal side of the dome formed by the collapsible portion 146 ′.
- the pinch point 126 ′ in the implanted shape can correspond to the pinch point 126 in the predetermined shape.
- FIG. 3 G illustrates a proximal tail 130 ′ of the braid 110 flattening to a ribbon shape and folding within a space defined by the inner sack 144 ′ and the dome of the collapsible portion 146 ′.
- the proximal tail 130 ′ can correspond to the proximal tail 130 of the braid in the predetermined shape as illustrated in FIG. 2 .
- the proximal tail 130 ′ can correspond to the flexible, proximal portion 116 illustrated in FIG. 1 .
- FIG. 3 H illustrates additional length of the proximal tail 130 ′ folding within the space defined by the inner sack 144 ′ and the dome of the collapsible portion 146 ′.
- FIG. 3 I illustrates the implant 100 in a final implanted shape.
- the outer section 142 ′, inner sack 144 ′, and collapsible portion 146 ′ are illustrated in cross-section to better illustrate the folded ribbon shape of the proximal tail 130 ′ extending from detachment key 150 .
- FIG. 4 illustrates an alternative implanted shape of a braid 110 .
- the braid 110 can include a twist 125 near the distal inversion 124 ′. Either with the twist 125 as illustrated in FIG. 4 , or without the twist, as illustrated in FIG. 3 I , the inner sack 144 ′ can provide a force F 1 pressing into the aneurysm wall 14 and/or the outer section 142 ′, depending on the coverage of the outer section 142 ′.
- the outer section 142 ′ is also illustrated in an alternative configuration such that the open end 114 is positioned approximate the distal portion 15 of the aneurysm wall 14 .
- FIGS. 5 A and 5 B illustrate subsequent implantation steps of the implant 100 illustrated in FIG. 4 .
- FIG. 5 A illustrates a second inner sack 132 expanding within the aforementioned, first inner sack 144 ′.
- FIG. 5 B illustrates the second inner sack 132 providing a second force F 2 pressing into the first inner sack 144 ′.
- the braid 110 is illustrated in cross section in FIG. 5 B .
- the braid 110 can form additional nested sacks. Additionally, or alternatively, the braid can collapse to form a ribbon shape and fold into a space defined by one or more nested sacks similar to as illustrated in FIGS. 3 G through 3 I .
- FIG. 6 illustrates an alternative implant 100 a including a braid 110 having two sections 116 , 118 of differing braid angle ⁇ 1 , ⁇ 4 , an embolic coil 160 , and a detachment key 150 .
- the embolic coil 160 can be attached to a proximal end 112 of the braid 110 .
- a proximal portion 116 of the braid 110 near the proximal end 112 can have a small braid angle ⁇ 4 .
- a distal portion 118 of the braid 110 near the distal end 114 of the braid can have a larger braid angle ⁇ 4 .
- the braid 110 can be shaped into a single layer tubular shape as illustrated in FIG. 6 .
- the braid can be shaped for delivery as described elsewhere herein.
- FIG. 7 illustrates an alternative implant 100 a such as the implant 100 a illustrated in FIG. 6 having a braid 110 in a predetermined shape.
- the predetermined shape can have four sections 142 , 144 , 146 , 130 , two inversions 122 , 124 , and a pinch point 126 similar to as described in relation to FIG. 2 .
- the embolic coil 160 can extend from the tail section 130 of the braid 110 . When implanted, the embolic coil 160 can take the place of some or all of the tail portion 130 ′ of the implant 100 illustrated in FIG. 3 I .
- FIG. 8 illustrates an implant 100 a such as the implant 100 a illustrated in FIG. 6 and/or FIG. 7 in an implanted shape.
- the braid 110 can have an outer section 142 ′ and an inner sack 144 ′ when implanted similar as disclosed in relation to FIG. 3 I and/or FIG. 4 .
- the embolic coil 160 can wind within the inner sack 144 ′.
- FIG. 9 is a flow diagram outlining example method steps for treating an aneurysm with an implant and/or system such as an example implant 100 , 100 a and/or system described herein, variations thereof, or alternative implant and/or system as would be appreciated and understood by a person ordinary skill in the art.
- an implant and/or system such as an example implant 100 , 100 a and/or system described herein, variations thereof, or alternative implant and/or system as would be appreciated and understood by a person ordinary skill in the art.
- a tubular braid having a stronger section and a weaker section can be selected.
- the selected tubular braid can include an example tubular braid 110 as described herein, a variation thereof, or an alternative thereto as would be appreciated and understood by a person of ordinary skill in the art.
- the stronger section can have a larger braid angle relative to the weaker section such that the strength of the braid sections is respectively determined at least in part by the respective braid angles.
- one or both of the stronger and weaker sections can be treated (e.g. heat treated) to modify material properties of one or both of the sections such that difference in strength between the two sections is determined at least in part by the treatment.
- the stronger section can have a greater number of strands compared to the weaker section such that the strength of the braid sections is respectively determined at least in part by the number of strands.
- the strands in the stronger section can have a larger diameter compared to the diameter of the strands in the weaker section such that the strength of the braid sections is respectively determined at least in part of the diameter of the strands.
- the strands in the stronger section and the weaker section can include differing materials such that the strength of the sections is respectively determined at least in part by the material properties of the strands.
- the braid can be delivered through a microcatheter to an aneurysm.
- the braid can be detachably attached to an elongated delivery system.
- the implant (and thereby the braid) can be attached to the delivery system at a distal end of the delivery system.
- the delivery system and the implant can be positioned within the microcatheter such that the delivery system extends from a proximal end of the microcatheter.
- a user e.g. physician
- a user can place the implant similar to as illustrated in FIGS. 3 A through 3 I , FIG. 4 , FIGS.
- FIG. 8 otherwise described herein, or as otherwise understood by a person of ordinary skill in the art according to the teachings herein by manipulating the portion of the delivery system extending from the proximal end of the microcatheter.
- the distal end of the braid can be positioned at a distal portion 15 of the aneurysm wall 14 .
- the distal end of the braid can be positioned as illustrated in FIG. 4 , FIGS. 5 A through 5 B , and/or FIG. 8 .
- the distal end of the braid can be positioned elsewhere, for instance within a middle third of the aneurysm wall 14 , about half way between the distal portion 15 of the wall 14 and the aneurysm neck 16 as illustrated in FIGS. 3 A through 3 I .
- the stronger section of the braid can be expanded to form an outer sack apposing the aneurysm wall 14 .
- the outer sack can be shaped similar to the outer sack 142 ′ illustrated in FIG. 4 , FIGS. 5 A through 5 B , and/or FIG. 8 .
- the stronger section of the braid can be expanded to form a bowl shape similar to the outer section 142 ′ shape illustrated in FIGS. 3 A through 3 I .
- a proximal inversion can be formed in the braid at the aneurysm's neck.
- the proximal inversion can be positioned similar to the proximal inversion 122 ′ illustrated in FIGS. 3 A through 3 I , FIG. 4 , FIGS. 5 A through 5 B , and/or FIG. 8 .
- the proximal inversion can be shaped similar to the proximal inversion 122 ′ illustrated in FIGS. 3 A through 3 I , FIG. 4 , FIGS. 5 A through 5 B , and/or FIG. 8 .
- the proximal inversion 122 ′ can define a boundary between the outer sack or outer section expanded in step 308 and an inverted portion positioned within the outer sack or outer section.
- the inverted portion can be expanded to form a sack inside the outer sack or outer section.
- the inverted portion can press against the outer sack (or section), thereby pressing the outer sack (or section) into the aneurysm wall 14 .
- the inverted portion can form an inner sack 144 ′ such as illustrated in FIGS. 3 A through 3 I , FIG. 4 , FIGS. 5 A through 5 B , and/or FIG. 8 .
- a distal inversion can be formed in the braid.
- the distal inversion can define a distal side of the inverted, inner sack expanded in step 312 .
- the distal inversion can define a boundary between the inner sack and an inner, non-inverted portion of the braid.
- the inner, non-inverted portion of the braid can include the weaker section of the braid.
- the weaker section of the braid can be positioned in the inverted sack.
- the weaker section can be flattened to a ribbon shape and folded into the inverted sack.
- the weaker section can be flattened and folded such as illustrated in FIGS. 3 G through 3 I , as otherwise described herein, and/or as understood by a person of ordinary skill in the art according to the teachings herein.
- the weaker section can correspond to the tail section 130 , 130 ′ of the braid 110 .
- the descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention.
- the invention contemplates many variations and modifications of the implant, including: alternative delivery methods, alternative braid materials, alternative means for achieving a desired stiffness/flexibility of braid material, additional structures affixed to the implant (e.g. to aid in anchoring the implant, blood flow diversion, embolism formation, etc.), alternative predetermined braid shapes (e.g. one inversion, three inversions, four inversions, five or more inversions, non-radially symmetric shapes, alternative segment shapes, etc.), alternative implanted shapes, etc. Modifications apparent to one of ordinary skill in the art following the teachings of this disclosure are intended to be within the scope of the claims which follow.
Abstract
A tubular braided implant is provided including a braid that can be delivered as a single layer braid, invert into itself during deployment to form at least two nested sacks and include additional braid material that can fill the innermost sack. The additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks. The braid can have a variable braid angle along its length such that when positioned for delivery, the can have a high braid angle near its distal end and a low braid angle near the proximal end. In addition, or as a replacement for the braid material that fills the innermost sack, the implant can include an embolic coil that can loop within the innermost sack.
Description
- The present application is a continuation application of U.S. patent application Ser. No. 16/703,973 filed Dec. 5, 2019, the entire contents of which are hereby incorporated by reference.
- The present invention generally relates to medical instruments, and more particularly, to embolic implants for aneurysm therapy.
- Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues. Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. Current alternatives to endovascular or other surgical approaches can include intravascularly delivered treatment devices that fill the sac of the aneurysm with embolic material or block the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm. When treating the aneurysm neck, blood flow into the entrance of the aneurysm is inhibited, inducing venous stasis in the aneurysm and facilitating a natural formation of a thrombotic mass within the aneurysm.
- Current intravascularly delivered devices typically utilize multiple embolic coils to either fill the sac or treat the entrance of the aneurysm. Naturally formed thrombotic masses formed by treating the entrance with embolic coils can result in improved healing compared to aneurysm masses packed with embolic coils because naturally formed thrombotic masses can reduce the likelihood of distention from arterial walls and facilitate reintegration into the original parent vessel shape along the neck plane. However, embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel, particularly if the entrance is overpacked. Conversely, if the entrance is insufficiently packed, blood flow can persist into the aneurysm. Treating certain aneurysm morphology (e.g. wide neck, bifurcation, etc.) can require ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density. Once implanted, the coils cannot easily be retracted or repositioned. Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, blood flow, or large aneurysm size.
- Alternatives to embolic coils are being explored, for example a tubular braided implant is disclosed in U.S. Patent Publication Number 2018/0242979, incorporated herein by reference. Tubular braided implants have the potential to easily, accurately, and safely treat an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel. Compared to embolic coils, however, tubular braided implants are a newer technology, and there is therefore capacity for improved geometries, configurations, delivery systems, etc. for the tubular braided implants.
- There is therefore a need for improved methods, devices, and systems for implants for aneurysm treatment.
- It is an object of the present invention to provide systems, devices, and methods to meet the above-stated needs. Generally, it is an object of the present invention to provide a tubular braided implant including a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack. The additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks. In order to have an implant that can invert and fill an aneurysm, the braid can be made such that the distal end, the braid is made stronger, having a tendency to move toward a predetermined shape when implanted and forming the two nested sacks, and at the proximal end, the braid can be made weaker, having a tendency to flatten and fold in a ribbon shape inside of the sacks. The braid can have a variable braid angle along its length such that when positioned for delivery, the braid can have a high braid angle near its distal end and a low braid angle near the proximal end. In addition to the variable braid angle, or as an alternative, the braid can be heat treated to weaken the braid at the proximal end. In addition, or as a replacement for the braid material that fills the innermost sack, the implant can include an embolic coil that can loop within the innermost sack.
- An example method for treating an aneurysm can include one or more of the following steps presented in no particular order. The example method can further include additional steps not listed here. A substantially tubular braid can be selected that has a first end, a second end, a first portion extending from the first end, and a second portion extending from the second end. The substantially tubular braid can be selected such that the braid, when in a single layer cylindrical shape having a uniform circumference along a length from one end of the braid to the other end of the braid, the braid has a smaller braid angle in the second portion of the braid compared to the first portion of the braid. The braid can be selected such that, when in the single layer cylindrical shape, the braid has a continuously decreasing braid angle extending from the first portion to the second portion.
- The braid can be delivered through a microcatheter to an aneurysm. The braid can be delivered in the single layer tubular shape such that the first end is positioned in the distal direction in relation to the second end.
- The first portion of the braid can be expanded to the aneurysm's wall. A proximal inversion can be formed in the braid at the aneurysm's neck. An inverted portion of the braid can be expanded to press into the expanded first portion. A distal inversion can be formed in the braid at a distal portion of the aneurysm's wall such that the inverted portion of the braid extends between the distal and proximal inversions.
- The braid can be shaped to form a dome near the distal portion of the aneurysm's wall within the inverted portion. Additionally, or alternatively, the braid can be twisted at the distal inversion and the braid can be expanded to form a sack within the inverted portion.
- The second portion of the braid can be positioned within the inverted portion, either directly in contact with the inverted portion, within sacks formed within the inverted portion, or otherwise positioned in the inverted portion. The second portion of the braid can be positioned such that the second portion is flattened and looped within the inverted portion.
- An embolic coil can be selected. The embolic coil can be positioned such that it is affixed to the second end of the braid. The embolic coil can be delivered through the microcatheter to the aneurysm. The embolic coil can be positioned within the inverted portion of the implanted braid.
- An example implant can include a tubular braid with two ends that is shapeable to a single layer cylindrical shape having a length measurable from one end to the other end, a substantially uniform circumference along the length, a larger braid angle on a first portion of the braid extending from a first of the two ends, and a smaller braid angel on a second portion of the braid extending from a second of the two ends. In the single layer cylindrical shape, the braid can have a continuously decreasing braid angle extending from the first portion to the second portion. In the single layer tubular shape, the braid can be sized to be delivered through a microcatheter to an aneurysm.
- The braid can be movable from the single layer cylindrical shape to an implanted shape. In the implanted shape, the first portion can be positioned to appose an aneurysm wall, an inverted sack can be positioned to press the first portion to the aneurysm wall, and the second portion can be positioned within the inverted sack. In the implanted shape, at least a portion of the second portion of the braid can be looped within the inverted portion. In the implanted shape, the second portion can be positioned to press the inverted portion to the first portion.
- In the implanted shape, an inner sack can be positioned to press the inverted sack to the first portion, the braid can have an inversion separating the inner sack and the inverted sack, and the braid can be twisted at the inversion.
- In the implanted shape, the braid can have a dome shape within the inverted sack positioned near a distal portion of the aneurysm's wall.
- The implant can further include an embolic coil affixed to the second end of the braid. In the implanted shape, the braid can be shaped to allow the embolic coil to be positioned within the inverted sack, either in direct contact with the inverted sack, separated from the inverted sack by braid material, or otherwise positioned in the inverted sack.
- Another example implant can include a tubular braid having a first end and a second end. The braid can have a predetermined shape having two inversions dividing the braid into three segments: an outer segment extending from the first end to a first inversion of the two inversions, a middle segment extending between the two inversions and at least partially surrounded by the outer segment, and an inner segment extending from the second of the two inversions to the second end and at least partially surrounded by the middle segment. In the predetermined shape, the braid can have an abrupt change in braid angle at a position on the inner segment such that a distal portion of the inner segment extending from the second inversion has a higher braid angle than a proximal portion of the inner segment extending from the second end.
- The braid can be movable to an implanted shape sized to be positioned within an aneurysm sac. In the implanted shape, a part of the braid corresponding to the inner segment in the predetermined shape can be collapsed to a ribbon shape and positioned in an inverted sack formed from a part of the braid corresponding to the middle segment in the predetermined shape.
- The braid can be shaped to a single layer cylindrical shape having a substantially uniform circumference between the two ends of the braid, a larger braid angle in a first portion of the braid extending from the first end, and a smaller braid angle in a second portion of the braid extending from the second end. In the single layer cylindrical shape, the braid can have a continuously decreasing braid angle from the first portion to the second portion. In the single layer cylindrical shape, the braid can be sized to be delivered through a microcatheter to an aneurysm.
- The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
-
FIG. 1 is an illustration of an implant having a braid shaped for delivery through a catheter according to aspects of the present invention; -
FIG. 2 is an illustration of an implant having a braid in a predetermined shape according to aspects of the present invention; -
FIGS. 3A through 3I are illustrations of steps of an aneurysm treatment process according to aspects of the present invention; -
FIG. 4 is an illustration of an implant having a braid twisting near a distal inversion according to aspects of the present invention; -
FIGS. 5A through 5B are illustrations of steps of an aneurysm treatment process according to aspects of the present invention; -
FIG. 6 is an illustration of an implant having a braid and an embolic coil each shaped for delivery through a catheter according to aspects of the present invention; -
FIG. 7 is an illustration of an implant having a braid and an embolic coil with the braid in a predetermined shape according to aspects of the present invention; -
FIG. 8 is an illustration of an implant having a braid and an embolic coil implanted in an aneurysm according to aspects of the present invention; and -
FIG. 9 is a flow diagram listing method steps that can be performed according to aspects of the present invention. - In known treatments of wide neck aneurysms, the aneurysm is typically treated by placing embolic coils within the aneurysm sac and placing a stent within the parent blood vessel across the aneurysm neck. The stent is necessary in many cases to inhibit the embolic coils from entering the parent blood vessel. If embolic coils enter the parent blood vessel, the coils can obstruct the vessel and/or clots can form on the coils within the blood vessel and create an obstruction in the parent blood vessel. Braided aneurysm intrasaccular implants can be used to treat wide neck aneurysms without requiring a stent to secure the braided implant at the aneurysm neck. However, to achieve the forces necessarily to anchor braided implants in a wide neck bifurcation, the braid can be stiff and resistant to reshaping to an implanted shape that is significantly different than a predetermined shape. It can therefore be challenging, in some cases, to pack the aneurysm with a sufficient braid density to quickly and effectively induce blood stasis within the aneurysm sac. A braid made too soft can compact in shape and cause the aneurysm to recanalize as the implant is no longer sealing the neck of the aneurysm.
- Aspects of the present invention are directed to address the above challenges. In examples presented herein, a tubular braided implant can include a braid that can be delivered as a single layer braid, can invert into itself during deployment to form at least two nested sacks, and can include additional braid material that can fill the innermost sack. The additional braid material can loop or coil like a ribbon and/or invert to form smaller and smaller nested sacks. An aspect of the present invention is to provide a structure that allows a sufficient amount of additional braid material to be placed into the innermost sack such that the aneurysm clots quickly for an effective treatment.
- When used herein, the terms “tubular” and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length. For simplicity, tubular structures are generally illustrated herein as having a substantially right cylindrical structure. However, a tubular structure can have a tapered or curved outer surface without departing from the scope of the present invention.
- To meet the competing needs for braid stiffness to achieve secure anchoring within the aneurysm and braid softness to deform the braid to a high packing density within the aneurysm, the braid can be made such that portions of the braid pushed into the aneurysm when the aneurysm has a higher packing density are weaker compared to stiffer portions of the braid that expand to anchor the braid within the aneurysm. Stiffness/flexibility of the braid portions can be controlled by braid angle (e.g. picks per inch), strand diameter, number of strands, material of strands, and/or treatment (e.g. heat treatment) to modify strand material properties, etc. A stiffer portion can have a higher braid angle, a larger strand diameter, more strands, strands comprising a stiffer material, and/or strands treated to have greater stiffness compared to a weaker portion.
- Stiffer portions of the braid can be positioned near a distal end of the braid when the braid is being delivered through a catheter so that the stiffer portions of the braid exit the catheter and expand to anchor in the aneurysm before the aneurysm is packed. Stiffer portions of the braid can be shaped in a predetermined shape by heat setting or other means such that when the stiffer portions, they expand toward the predetermined shape. The tendency of the stiffer portions of the braid to expand toward the predetermined shape can create sufficient force against the aneurysm walls to anchor the braid in the aneurysm sac. Weaker portions of the braid can be positioned near the proximal end of the braid when the braid is delivered through the catheter. Portions of the braid which have the most flexibility can be dynamically deformed to loop or nest within the aneurysm, folding within the stiffer, anchoring portions of braid.
- In addition, or as a replacement for the braid material that fills the innermost sack, the implant can include an embolic coil that can loop within the innermost sack.
- Examples presented herein generally include a braided implant that can secure within an aneurysm sac and occlude a majority of the aneurysm's neck. The implant can include a tubular braid having a stiffer portion and a weaker portion, at least the stiffer portion being set into a predetermined shape, the braid being compressible for delivery through a microcatheter, and the braid being implantable in an implanted position that is based on the geometry of the aneurysm in which the braid is implanted and based at least in part on the predetermined shape.
- An
example implant 100, as illustrated inFIG. 1 can include abraid 110 that can be shaped into a substantially tubular, single layer shape having a length L measured between eachend - In the single layer tubular shape illustrated in
FIG. 1 , thebraid 110 can have a circumference C that is substantially uniform along the length L. The tubular shape can have a central axis A extending along the length of thebraid 110. A braid angle θ1, θ2, θ3, θ4 can be measured by comparing the tangential trajectory of a braid strand to the central axis A as illustrated and as would otherwise be understood by a person of ordinary skill in the art according to the teachings herein. - The braid can include a number of strands, for example, from about 4 to about 96 strands, each extending from one
braid end 112 to the other 114. As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%. The strands can wrap helically around the circumference C. The number of strands, angle of strands, diameter of the strands, material of strands, and material properties of strands, can all be factors in controlling material properties of thebraid 110, including porosity and flexibility. Braid strands can be woven such that about half of the strands wrap in a clockwise helix, the other half wraps in a counterclockwise helix, and the oppositely wrapping strands cross over and under each other in an alternating fashion. Constructed as such, portions of the braid having a higher braid angle can therefore having a higher density of strands compared to portions of the braid having lower braid angle. Higher strand density can result in a denser, stiffer braid portion. - The strands can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, platinum, nitinol, stainless steel, tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time. Some or all of
braid 110 can be a multi-filament cylindrical mesh made preferably of nitinol with interwoven platinum filaments for radiopacity or Drawn Filled Tube (DFT) Nitinol with about 10 to about 40% platinum. The apertures in the mesh ofbraid 110 can also create a substantially unitary frame work or mesh. Thus, the apertures can have variable size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh ofbraid 110. The apertures can provide thebraid 110 with flexibility and also assist in the transformation of the braid from the collapsed state to the expanded, deployed state, and vice versa. - The
braid 110 as illustrated inFIG. 1 depicts four braid angles θ1, θ2, θ3, θ4 that increase as measured from theproximal end 112 of thebraid 110 to thedistal end 114 with the braid angle θ4 in theproximal portion 116 of thebraid 110 being the smallest, the braid angle θ3 in the section immediate distal to theproximal portion 116 being larger than the braid angle θ4 in theproximal portion 116, the braid angle θ2 in the next distal section being larger than the angle θ3 in the section immediately proximal to it, and the braid angle θ1 in the distalmost section 118 of thebraid 110 being the largest. As would be appreciated and understood, thebraid 110 can include two or more sections having differing braid angles and thereby differing stiffness/flexibility. The braid can additionally include a continuous gradient change in braid angle and thereby continuous gradient change in stiffness/flexibility from one braid section to another, for instance the braid angle can change continuously from theproximal portion 116 to thedistal portion 118. - The
implant 100 can be delivered to an aneurysm when thebraid 110 is sized to traverse a catheter. For instance, thebraid 110 can be delivered in the single-layer tubular shape as illustrated inFIG. 1 such that one end of thebraid 114 is a distal end positioned to exit the catheter before the remainder of thebraid 110 and theother end 112 is a proximal end positioned to exit the catheter after the remainder of thebraid 110. Alternatively, the braid can be delivered in other shapes that include folds, inversions, and/or multiple layers. Regardless of the delivery shape, thebraid 110 can have adistal portion 118 positioned to exit the catheter before the remainder of thebraid 110 and aproximal portion 116 positioned to exit the catheter after the remainder of thebraid 110. Thedistal portion 118 can have a high braid angle θ1 such that thedistal portion 118 has sufficient stiffness to anchor thebraid 110 within the aneurysm. Theproximal portion 116 can have a low braid angle θ4 such that the proximal portion has sufficient flexibility to collapse into an aneurysm sac containing the remainder ofbraid 110. Theimplant 100 can further include adetachment feature 150 configured to be detachably attached to an implant delivery system. Thedetachment feature 150 can be affixed to thebraid 110 at theproximal end 112 of thebraid 110. -
FIG. 2 illustrates abraid 110 such as thebraid 110 illustrated inFIG. 1 shaped into a predetermined shape. Thebraid 110 can include a memory shape material such as Nitinol, a Nitinol alloy, a polymer memory shape material, or other memory shape material having properties for reshaping as described herein. Thebraid 110 can be set to the predetermined shape by heat setting or other means as appreciated and understood by a person of ordinary skill in the art. Thebraided segment 110 can be collapsed from the predetermined shape to a deformed shape sized to traverse a microcatheter to an aneurysm. Upon contact with blood when exiting the microcatheter, thebraid 110 can move from the deformed shape toward the predetermined shape. The anatomy of the aneurysm and treatment site can inhibit thebraid 110 from moving to the predetermined shape such that when thebraid 110 is deployed, it can take on a deployed shape that is based in part on the predetermined shape and the shape of the anatomy in which the braid is implanted. - In the predetermined shape, the
braid 110 can include twoinversions pinch point 126 dividing thebraid 110 into foursegments braid 110 can have anouter segment 142 extending from theopen end 114 of thebraid 110 to afirst inversion 122 of the twoinversions middle segment 144 extending between the twoinversions inner segment 146 extending from asecond inversion 124 of the twoinversions pinch point 126 of thebraid 110, and anelongated section 130 extending from thepinch point 126 to anopposite end 112 of thebraid 110. When in the predetermined shape, thetubular braid 110 can be substantially radially symmetrical around a central vertical axis y. -
FIG. 2 illustrates a profile of eachsegment detachment feature 150 is illustrated as a flat key that can be used with a mechanical implant delivery system (not illustrated). Example implant delivery systems are described, for instance, in U.S. Patent Application Publication Numbers 2019/0192162 and 2019/0328398 each incorporated herein by reference as if set for in their entireties herein. During delivery and/or positioning of the implant, the key 150 can be visualized radiographically. The key 150 can be released from the delivery system, thereby releasing theimplant 100 from the delivery system. When the implant is released, the key can remain attached to the implant. - The
tubular braid 110 can be formed into the predetermined shape by first pinching thebraid 110 at thepinch point 126, then inverting the braid outwardly to separate theinner segment 146 from themiddle segment 144 with aninversion 124, then shaping themiddle segment 144 over a form to produce the substantially “S” shaped profile illustrated, and finally, inverting thebraid 110 outwardly again to separate themiddle segment 144 from theouter segment 142 with anotherinversion 122. Optionally, the braid can be trimmed at theopen end 114 and/or theproximal end 112. Theopen end 114 can be positioned to encircle themiddle segment 144. Theopen end 114 can positioned within the middle third section of the braid's height as illustrated. Alternatively, theopen end 114 can be positioned elsewhere, such as near thedistal inversion 124. - The
outer sack 142 can correspond to thedistal portion 118 of thebraid 110 as illustrated inFIG. 1 . Thedistal portion 118 can have a substantially uniform braid angle θ1 along its length when the single layer tubular shape illustrated inFIG. 1 Thebraid 110 can have an abrupt braid angle change at theproximal inflection 122. Thebraid 110 can have a graduated braid angle change through themiddle section 144 andinner section 146. Thetail 130 can have a braid angle θ4 that is substantially consistent along the length of thetail 130. Thetail 130 can correspond to theproximal portion 116 of thebraid 110 in the single layer tubular shape as illustrated inFIG. 1 . - Alternatively,
sections pinch point 126 can have a high braid angle θ1 that is consistent along the length of thosesections braid 110 is in a single layer tubular shape, thetail section 130 can have a low braid angle θ4 consistent along its length, and thebraid 110 can have an abrupt change in braid angle at thepinch point 126. Thetail 130 can be sufficiently flexible such that, when manipulated at an intravascular treatment site, it flattens to a ribbon shape and folds onto itself. Alternatively, braid 110 can include an abrupt braid angle change at theproximal inflection 122, at thedistal inflection 124, at thepinch point 126, or any combination thereof. - Strands of the
braid 110 at theopen end 114 can be free, cut ends; or, alternatively, the strands at theopen end 114 be closed, meaning strands within the braid at theopen end 114 are attached to each other by glue, weld, etc. or the strands bend back at theopen end 114. Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends. -
FIGS. 3A through 3I illustrate animplant 100 such as theimplant 100 illustrated inFIGS. 1 and/or 2 being implant in ananeurysm 10 via acatheter 20. The size of thecatheter 20 can be selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site. Thecatheter 20 can have a total usable length from about 80 centimeters to about 170 centimeters. Thecatheter 20 can have an inner diameter ID of from about 0.015 to about 0.032 inches. The outer diameter OD can also range in size and may narrow at either its proximal end or distal end. At its proximal end 26, thecatheter 20 can be manually operated by the end-user, and at its distal end can be operable, as illustrated, to be positioned at theneck 16 of theaneurysm 10. While the distal end of thecatheter 20 can contain theimplant 100, the distal end can be varied in shape and can curve at an angle. -
FIG. 3A illustrates theopen end 114 of thebraid 110 expanding within asac 12 of theaneurysm 10 to contactwalls 14 of theaneurysm 10. Thesection 142′ contacting theaneurysm wall 14 can correspond to the outer 142 section in the predetermined shape illustrated inFIG. 2 and/or the distal,stiffer portion 118 of thebraid 110 illustrated inFIG. 1 . Theimplant 100 can be selected for treatment such that the selectedimplant 100 has anouter segment 142 in the predetermined shape having a circumference greater than the circumference of theaneurysm sac 12, meaning thesection 142′ of thebraid 110 contacting the aneurysm wall provides a force against theaneurysm wall 14 as it tends to expand to the predetermined shape. The implanted shape of theouter section 142′ can thereby be smaller in circumference than the predetermined shape of theouter section 142. -
FIG. 3B illustrates thebraid 110 inverting to form aproximal inversion 122′ in the implanted shape. Theproximal inversion 122′ can correspond to theproximal inversion 122 in the predetermined shape. -
FIG. 3C illustrates thebraid 110 expanding within theouter section 142′. -
FIG. 3D illustrates the braid forming aninner sack 144′ inside of theouter section 142′. Adistal inversion 124′ is illustrated positioned near adistal portion 15 of theaneurysm wall 14. Thedistal inversion 124′ can correspond to adistal inversion 124 of thebraid 110 in the predetermined shape. Theinner sack 144′ can correspond to themiddle segment 144 in the predetermined shape illustrated inFIG. 2 . Theinner sack 144′ can correspond to the stiff,distal portion 118 of thebraid 110 illustrated inFIG. 1 and/or a portion of thebraid 110 having less stiffness than thedistal portion 118. Theinner sack 144′ can correspond to a portion of thebraid 110 having greater stiffness than the flexibleproximal portion 116 illustrated inFIG. 1 . -
FIG. 3E illustrates acollapsible portion 146′ of thebraid 110 further exiting thecatheter 20 and expanding within theinner sack 144′. Thecollapsible portion 146′ can correspond to theinner segment 146 of thebraid 110 in the predetermined shape. Thecollapsible portion 146′ can correspond to the stiff,distal portion 118 of thebraid 110 illustrated inFIG. 1 and/or a portion of thebraid 110 having less stiffness than the distal portion. Thecollapsible portion 146′ can correspond to a portion of thebraid 110 having greater stiffness than the flexibleproximal portion 116 illustrated inFIG. 1 . -
FIG. 3F illustrates thecollapsible portion 146′ forming a dome near thedistal inversion 124′. Apinch point 126′ is illustrated on the proximal side of the dome formed by thecollapsible portion 146′. Thepinch point 126′ in the implanted shape can correspond to thepinch point 126 in the predetermined shape. -
FIG. 3G illustrates aproximal tail 130′ of thebraid 110 flattening to a ribbon shape and folding within a space defined by theinner sack 144′ and the dome of thecollapsible portion 146′. Theproximal tail 130′ can correspond to theproximal tail 130 of the braid in the predetermined shape as illustrated inFIG. 2 . Theproximal tail 130′ can correspond to the flexible,proximal portion 116 illustrated inFIG. 1 . -
FIG. 3H illustrates additional length of theproximal tail 130′ folding within the space defined by theinner sack 144′ and the dome of thecollapsible portion 146′. -
FIG. 3I illustrates theimplant 100 in a final implanted shape. Theouter section 142′,inner sack 144′, andcollapsible portion 146′ are illustrated in cross-section to better illustrate the folded ribbon shape of theproximal tail 130′ extending fromdetachment key 150. -
FIG. 4 illustrates an alternative implanted shape of abraid 110. As illustrated inFIG. 4 , thebraid 110 can include atwist 125 near thedistal inversion 124′. Either with thetwist 125 as illustrated inFIG. 4 , or without the twist, as illustrated inFIG. 3I , theinner sack 144′ can provide a force F1 pressing into theaneurysm wall 14 and/or theouter section 142′, depending on the coverage of theouter section 142′. Theouter section 142′ is also illustrated in an alternative configuration such that theopen end 114 is positioned approximate thedistal portion 15 of theaneurysm wall 14. -
FIGS. 5A and 5B illustrate subsequent implantation steps of theimplant 100 illustrated inFIG. 4 .FIG. 5A illustrates a secondinner sack 132 expanding within the aforementioned, firstinner sack 144′.FIG. 5B illustrates the secondinner sack 132 providing a second force F2 pressing into the firstinner sack 144′. Thebraid 110 is illustrated in cross section inFIG. 5B . In subsequent implantation steps, thebraid 110 can form additional nested sacks. Additionally, or alternatively, the braid can collapse to form a ribbon shape and fold into a space defined by one or more nested sacks similar to as illustrated inFIGS. 3G through 3I . -
FIG. 6 illustrates an alternative implant 100 a including abraid 110 having twosections embolic coil 160, and adetachment key 150. Theembolic coil 160 can be attached to aproximal end 112 of thebraid 110. Aproximal portion 116 of thebraid 110 near theproximal end 112 can have a small braid angle θ4. Adistal portion 118 of thebraid 110 near thedistal end 114 of the braid can have a larger braid angle θ4. Thebraid 110 can be shaped into a single layer tubular shape as illustrated inFIG. 6 . The braid can be shaped for delivery as described elsewhere herein. -
FIG. 7 illustrates an alternative implant 100 a such as the implant 100 a illustrated inFIG. 6 having abraid 110 in a predetermined shape. The predetermined shape can have foursections inversions pinch point 126 similar to as described in relation toFIG. 2 . Theembolic coil 160 can extend from thetail section 130 of thebraid 110. When implanted, theembolic coil 160 can take the place of some or all of thetail portion 130′ of theimplant 100 illustrated inFIG. 3I . -
FIG. 8 illustrates an implant 100 a such as the implant 100 a illustrated inFIG. 6 and/orFIG. 7 in an implanted shape. Thebraid 110 can have anouter section 142′ and aninner sack 144′ when implanted similar as disclosed in relation toFIG. 3I and/orFIG. 4 . Theembolic coil 160 can wind within theinner sack 144′. -
FIG. 9 is a flow diagram outlining example method steps for treating an aneurysm with an implant and/or system such as anexample implant 100, 100 a and/or system described herein, variations thereof, or alternative implant and/or system as would be appreciated and understood by a person ordinary skill in the art. - Referring to
method 300 outlined inFIG. 9 , in step 302 a tubular braid having a stronger section and a weaker section can be selected. The selected tubular braid can include an exampletubular braid 110 as described herein, a variation thereof, or an alternative thereto as would be appreciated and understood by a person of ordinary skill in the art. The stronger section can have a larger braid angle relative to the weaker section such that the strength of the braid sections is respectively determined at least in part by the respective braid angles. Additionally, or alternatively, one or both of the stronger and weaker sections can be treated (e.g. heat treated) to modify material properties of one or both of the sections such that difference in strength between the two sections is determined at least in part by the treatment. Additionally, or alternatively, the stronger section can have a greater number of strands compared to the weaker section such that the strength of the braid sections is respectively determined at least in part by the number of strands. Additionally, or alternatively, the strands in the stronger section can have a larger diameter compared to the diameter of the strands in the weaker section such that the strength of the braid sections is respectively determined at least in part of the diameter of the strands. Additionally, or alternatively, the strands in the stronger section and the weaker section can include differing materials such that the strength of the sections is respectively determined at least in part by the material properties of the strands. - In step 304, the braid can be delivered through a microcatheter to an aneurysm. The braid can be detachably attached to an elongated delivery system. The implant (and thereby the braid) can be attached to the delivery system at a distal end of the delivery system. The delivery system and the implant can be positioned within the microcatheter such that the delivery system extends from a proximal end of the microcatheter. A user (e.g. physician) can deliver the implant through the microcatheter by manipulating the portion of the delivery system that extends out of the proximal end of the microcatheter. A user can place the implant similar to as illustrated in
FIGS. 3A through 3I ,FIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 , otherwise described herein, or as otherwise understood by a person of ordinary skill in the art according to the teachings herein by manipulating the portion of the delivery system extending from the proximal end of the microcatheter. - In
step 306, the distal end of the braid can be positioned at adistal portion 15 of theaneurysm wall 14. The distal end of the braid can be positioned as illustrated inFIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 . Alternatively, the distal end of the braid can be positioned elsewhere, for instance within a middle third of theaneurysm wall 14, about half way between thedistal portion 15 of thewall 14 and theaneurysm neck 16 as illustrated inFIGS. 3A through 3I . - In
step 308, the stronger section of the braid can be expanded to form an outer sack apposing theaneurysm wall 14. The outer sack can be shaped similar to theouter sack 142′ illustrated inFIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 . Alternatively, the stronger section of the braid can be expanded to form a bowl shape similar to theouter section 142′ shape illustrated inFIGS. 3A through 3I . - In
step 310, a proximal inversion can be formed in the braid at the aneurysm's neck. The proximal inversion can be positioned similar to theproximal inversion 122′ illustrated inFIGS. 3A through 3I ,FIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 . The proximal inversion can be shaped similar to theproximal inversion 122′ illustrated inFIGS. 3A through 3I ,FIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 . Theproximal inversion 122′ can define a boundary between the outer sack or outer section expanded instep 308 and an inverted portion positioned within the outer sack or outer section. - In
step 312, the inverted portion can be expanded to form a sack inside the outer sack or outer section. The inverted portion can press against the outer sack (or section), thereby pressing the outer sack (or section) into theaneurysm wall 14. The inverted portion can form aninner sack 144′ such as illustrated inFIGS. 3A through 3I ,FIG. 4 ,FIGS. 5A through 5B , and/orFIG. 8 . - In
step 314, a distal inversion can be formed in the braid. The distal inversion can define a distal side of the inverted, inner sack expanded instep 312. The distal inversion can define a boundary between the inner sack and an inner, non-inverted portion of the braid. The inner, non-inverted portion of the braid can include the weaker section of the braid. - In
step 316, the weaker section of the braid can be positioned in the inverted sack. The weaker section can be flattened to a ribbon shape and folded into the inverted sack. The weaker section can be flattened and folded such as illustrated inFIGS. 3G through 3I , as otherwise described herein, and/or as understood by a person of ordinary skill in the art according to the teachings herein. The weaker section can correspond to thetail section braid 110. - The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. The invention contemplates many variations and modifications of the implant, including: alternative delivery methods, alternative braid materials, alternative means for achieving a desired stiffness/flexibility of braid material, additional structures affixed to the implant (e.g. to aid in anchoring the implant, blood flow diversion, embolism formation, etc.), alternative predetermined braid shapes (e.g. one inversion, three inversions, four inversions, five or more inversions, non-radially symmetric shapes, alternative segment shapes, etc.), alternative implanted shapes, etc. Modifications apparent to one of ordinary skill in the art following the teachings of this disclosure are intended to be within the scope of the claims which follow.
Claims (20)
1. A method comprising:
selecting a substantially tubular braid comprising a first end, a second end, a length therebetween, a first portion extending from the first end, a middle portion extending from the first portion, and a collapsible portion extending from the second end such that the tubular braid is shapeable to a single layer cylindrical shape comprising a substantially uniform circumference along the length, a first braid angle in the first portion, and a second braid angle in the second portion, the second braid angle measuring less than the first braid angle;
delivering the tubular braid through a microcatheter to an aneurysm;
expanding the first portion of the braid to appose the aneurysm's wall;
forming a proximal inversion of the braid approximate the aneurysm's neck;
expanding an inverted portion of the middle portion to press the first portion to the aneurysm's wall;
forming a distal inversion of the braid approximate the distal portion of the aneurysm's wall such that the inverted portion extends from the proximal inversion to the distal inversion; and
positioning the collapsible portion of the braid within the inverted portion approximate the distal inversion.
2. The method of claim 1 , wherein selecting the substantially tubular braid further comprises selecting the tubular braid such that the single layer cylindrical shape further comprises a continuously decreasing braid angle extending from the first portion to the collapsible portion.
3. The method of claim 1 , wherein positioning the second portion of the braid further comprises flattening a proximal tail portion of the collapsible portion of the braid to a ribbon shape and looping the ribbon shape within the inverted portion.
4. The method of claim 1 , further comprising:
shaping the collapsible portion of the braid to form a dome within the inverted portion, the dome positioned approximate the distal portion of the aneurysm wall, the collapsible portion having a pinch point on a proximal side of the dome.
5. The method of claim 1 , further comprising:
twisting the braid approximate the distal inversion; and
expanding the braid to form a sack within the inverted portion.
6. The method of claim 1 , wherein delivering the tubular braid further comprises delivering the tubular braid in the single layer cylindrical shape such that the first end is positioned in the distal direction in relation to the second end.
7. The method of claim 1 , further comprising:
selecting an embolic coil;
positioning the embolic coil such that it is affixed to the tubular braid approximate the collapsible end of the braid;
delivering the embolic coil through the microcatheter to the aneurysm; and
positioning the embolic coil within the inverted portion.
8. An implant comprising:
a substantially tubular braid shapeable to a single layer cylindrical shape and movable to an implanted shape, the braid comprising:
a first end;
a second end;
a length measurable from the first end to the second end;
a first portion extending from the first end;
a middle portion extending from the first portion;
a collapsible portion extending from the second end and comprising a proximal tail;
the single layer cylindrical shape comprises a substantially uniform circumference along the length, a first braid angle in the first portion, and a second braid angle in the second portion, the second braid angle measuring less than the first braid angle;
wherein, in the implanted shape, the first portion is configured to be positioned to appose an aneurysm wall, an inverted sack is formed by a proximal inversion of the braid approximate an aneurysm neck, the inverted sack being expandable and positioned to press the first portion to the aneurysm wall, and the middle portion is positioned within the inverted sack, and
wherein, in the implanted shape, the collapsible portion of the braid is positioned within the inverted portion approximate the distal inversion.
9. The implant of claim 8 ,
wherein, in the single layer cylindrical shape, the braid comprises a continuously decreasing braid angle extending from the first portion to the collapsible portion.
10. The implant of claim 8 ,
wherein, in the implanted shape, at least a portion of the proximal tail of the braid is looped within the distal inversion.
11. The implant of claim 8 , wherein, in the implanted shape, the middle portion is configured to be expanded to form an inner sack, the inner sack is positioned to press the inverted sack to the first portion, the braid comprises a distal inversion configured to be approximate a distal portion of the aneurysm wall such that the inverted sack extends from the proximal inversion to the distal inversion and separates the inner sack and the inverted sack, wherein the first end terminates proximal of the distal inversion, and the braid is twisted approximate the distal inversion.
12. The implant of claim 8 , wherein, in the implanted shape, the collapsible portion of the braid is configured to form a dome within the inverted portion, the dome positioned approximate the distal portion of the aneurysm wall, the collapsible portion comprising a pinch point on a proximal side of the dome.
13. The implant of claim 8 ,
wherein, when the braid is in the single layer cylindrical shape, the braid is sized to be delivered through a microcatheter to an aneurysm, and
wherein the braid is movable from the single layer cylindrical shape to the implanted shape.
14. The implant of claim 8 , further comprising:
an embolic coil affixed to the tubular braid approximate the collapsible end of the braid,
wherein, in the implanted shape, the braid is shaped to allow the embolic coil to be positioned within the inverted sack.
15. An implant comprising:
a substantially tubular braid comprising a first end, a second end, and a predetermined shape, the tubular braid movable to an implanted shape sized to be positioned in an aneurysm sac,
wherein, in the predetermined shape, the tubular braid comprises: a first inversion, an outer segment extending from the first end to the first inversion, a second inversion, a middle segment extending from the first inversion to the second inversion, and an inner segment extending from the second inversion to the second end such that the outer segment at least partially surrounds the middle segment, and the middle segment at least partially surrounds the inner segment,
wherein, in the implanted shape, the first inversion is approximate an aneurysm neck and is configured to be expanded to form an inverted sack, such that the inverted sack extends from the first inversion to the second inversion, the second inversion is approximate a distal portion of the aneurysm wall, the middle segment is configured to be expanded to form an inner sack positioned to press the inverted sack to the outer segment, the second inversion is configured to separate the inner sack and the inverted sack, the inner segment of the braid is positioned within the inverted portion approximate the second inversion, the first end terminates proximal of the second inversion, and
wherein, in the implanted shape, at least a portion of the tubular braid corresponding to the inner segment in the predetermined shape is collapsed to a ribbon shape and is positioned in an inverted sack corresponding to the middle segment in the predetermined shape.
16. The implant of claim 15 ,
wherein the tubular braid is shapeable to a single layer cylindrical shape, and
wherein, in the single layer cylindrical shape, the braid comprises a substantially uniform circumference between the first end and the second end, a first braid angle in a first portion of the braid extending from the first end, and a second braid angle in a second portion of the braid extending from the second end, the second braid angle measuring less than the first braid angle.
17. The implant of claim 16 , wherein, in the single layer cylindrical shape, the braid comprises a continuously decreasing braid angle extending from the first portion to the second portion.
18. The implant of claim 15 , wherein, in the implanted shape, the inner segment of the braid is configured to form a dome within the inverted portion, the dome positioned approximate a distal portion of the aneurysm wall, the inner segment comprising a pinch point on a proximal side of the dome, and the braid is twisted approximate the second inversion.
19. The implant of claim 15 , further comprising:
an embolic coil affixed to the tubular braid approximate the second end of the braid.
20. The implant of claim 15 ,
wherein, in the predetermined shape, the tubular braid comprises an abrupt change in braid angle at a position in the inner segment, and
wherein a distal portion of the inner segment extending from the second inversion has a greater braid angle than a proximal portion of the inner segment extending from the second end of the braid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/969,851 US20230062395A1 (en) | 2019-12-05 | 2022-10-20 | Intrasaccular inverting braid with highly flexible fill material |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/703,973 US11602350B2 (en) | 2019-12-05 | 2019-12-05 | Intrasaccular inverting braid with highly flexible fill material |
US17/969,851 US20230062395A1 (en) | 2019-12-05 | 2022-10-20 | Intrasaccular inverting braid with highly flexible fill material |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/703,973 Continuation US11602350B2 (en) | 2019-05-21 | 2019-12-05 | Intrasaccular inverting braid with highly flexible fill material |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230062395A1 true US20230062395A1 (en) | 2023-03-02 |
Family
ID=73726734
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/703,973 Active US11602350B2 (en) | 2019-05-21 | 2019-12-05 | Intrasaccular inverting braid with highly flexible fill material |
US17/969,851 Pending US20230062395A1 (en) | 2019-12-05 | 2022-10-20 | Intrasaccular inverting braid with highly flexible fill material |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/703,973 Active US11602350B2 (en) | 2019-05-21 | 2019-12-05 | Intrasaccular inverting braid with highly flexible fill material |
Country Status (5)
Country | Link |
---|---|
US (2) | US11602350B2 (en) |
EP (1) | EP3831316A3 (en) |
JP (1) | JP2021087772A (en) |
KR (1) | KR20210070916A (en) |
CN (1) | CN112914656A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
KR102442152B1 (en) | 2021-06-01 | 2022-09-08 | 주식회사 다스 | Walk-in device for seat |
Family Cites Families (405)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2849002A (en) | 1956-03-12 | 1958-08-26 | Vincent J Oddo | Haemostatic catheter |
US3480017A (en) | 1966-04-27 | 1969-11-25 | Wallace B Shute | Cervical dilator |
US4085757A (en) | 1976-04-29 | 1978-04-25 | P Pevsner | Miniature balloon catheter method and apparatus |
US4282875A (en) | 1979-01-24 | 1981-08-11 | Serbinenko Fedor A | Occlusive device |
US4395806A (en) | 1980-05-08 | 1983-08-02 | Sorenson Research Co., Inc. | Method of manufacturing a detachable balloon catheter assembly |
US4364392A (en) | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4545367A (en) | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
US4517979A (en) | 1983-07-14 | 1985-05-21 | Cordis Corporation | Detachable balloon catheter |
WO1988003817A1 (en) | 1986-11-29 | 1988-06-02 | Terumo Kabushiki Kaisha | Catheter equipped with balloon |
US4836204A (en) | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US5067489A (en) | 1988-08-16 | 1991-11-26 | Flexmedics Corporation | Flexible guide with safety tip |
FR2641692A1 (en) | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US4991602A (en) | 1989-06-27 | 1991-02-12 | Flexmedics Corporation | Flexible guide wire with safety tip |
US5065772A (en) | 1989-10-13 | 1991-11-19 | Inamed Corporation | Inflatable cerivical pessary |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US6425893B1 (en) | 1990-03-13 | 2002-07-30 | The Regents Of The University Of California | Method and apparatus for fast electrolytic detachment of an implant |
JPH0546421Y2 (en) | 1990-08-23 | 1993-12-06 | ||
US5025060A (en) | 1990-10-15 | 1991-06-18 | Kansai Paint Co., Ltd. | Dispersion of fine particles of a polymer |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
ATE187053T1 (en) | 1991-12-12 | 1999-12-15 | Target Therapeutics Inc | UNCOUPLING, SLIDING, VESSEL-OCCLOSING SPIRAL WITH INTERLOCKING COUPLING ELEMENTS |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5624449A (en) | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
JP2605559Y2 (en) | 1993-12-21 | 2000-07-24 | 株式会社パイオラックス | Treatment device for tubular organs |
US5846261A (en) | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
WO1996001591A1 (en) | 1994-07-08 | 1996-01-25 | Microvena Corporation | Method of forming medical devices; intravascular occlusion devices |
US5814062A (en) | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
IL116561A0 (en) | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
RU2157146C2 (en) | 1995-06-13 | 2000-10-10 | ВИЛЬЯМ КУК Европа, A/S | Device for performing implantation in blood vessels and hollow organs |
US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US6949116B2 (en) | 1996-05-08 | 2005-09-27 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ including biodegradable elements |
US5964797A (en) * | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
US5941249A (en) | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
US6007573A (en) | 1996-09-18 | 1999-12-28 | Microtherapeutics, Inc. | Intracranial stent and method of use |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
DE69835958T2 (en) | 1997-08-04 | 2007-02-15 | Boston Scientific Ltd., Barbados | OCCLUSION SYSTEM FOR IMPROVING ANEURYSMAS |
GB9716497D0 (en) | 1997-08-05 | 1997-10-08 | Bridport Gundry Plc | Occlusion device |
US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
JP4127960B2 (en) | 1997-08-05 | 2008-07-30 | ボストン サイエンティフィック リミテッド | Detachable aneurysm neck bridge |
US6086577A (en) | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6146373A (en) | 1997-10-17 | 2000-11-14 | Micro Therapeutics, Inc. | Catheter system and method for injection of a liquid embolic composition and a solidification agent |
US6036720A (en) | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
ATE454098T1 (en) | 1998-02-10 | 2010-01-15 | Artemis Medical Inc | OCCLUSION, ANCHORING, CHIPING OR POWER CONTROL DEVICE |
US6379374B1 (en) | 1998-10-22 | 2002-04-30 | Cordis Neurovascular, Inc. | Small diameter embolic coil hydraulic deployment system |
US6063100A (en) | 1998-03-10 | 2000-05-16 | Cordis Corporation | Embolic coil deployment system with improved embolic coil |
US5925060A (en) | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
AU3454999A (en) | 1998-03-30 | 1999-10-18 | University Of Virginia Patent Foundation | Flow arrest, double balloon technique for occluding aneurysms or blood vessels |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
SE514546C2 (en) | 1998-05-18 | 2001-03-12 | Allgon Ab | An antenna system and a radio communication device comprising an antenna system |
US6463317B1 (en) | 1998-05-19 | 2002-10-08 | Regents Of The University Of Minnesota | Device and method for the endovascular treatment of aneurysms |
US6113609A (en) | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US5935148A (en) | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6096175A (en) | 1998-07-17 | 2000-08-01 | Micro Therapeutics, Inc. | Thin film stent |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
WO2000013593A1 (en) | 1998-09-04 | 2000-03-16 | Boston Scientific Limited (Incorporated In Ireland) | Detachable aneurysm neck closure patch |
WO2000021443A1 (en) | 1998-10-09 | 2000-04-20 | Cook Incorporated | Vasoocclusion coil device having a core therein |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US8016852B2 (en) | 1998-11-10 | 2011-09-13 | Stryker Corporation | Bioactive components for incorporation with vaso-occlusive members |
US6569179B2 (en) | 1998-11-10 | 2003-05-27 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US6080183A (en) | 1998-11-24 | 2000-06-27 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
EP3173035A1 (en) | 1999-02-01 | 2017-05-31 | Board of Regents, The University of Texas System | Woven intravascular devices |
US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6375606B1 (en) | 1999-03-17 | 2002-04-23 | Stereotaxis, Inc. | Methods of and apparatus for treating vascular defects |
US6858034B1 (en) | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6379329B1 (en) | 1999-06-02 | 2002-04-30 | Cordis Neurovascular, Inc. | Detachable balloon embolization device and method |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6994092B2 (en) | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
US6331184B1 (en) | 1999-12-10 | 2001-12-18 | Scimed Life Systems, Inc. | Detachable covering for an implantable medical device |
US6350270B1 (en) | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6346117B1 (en) | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US7153323B1 (en) | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
US20020068974A1 (en) | 2000-07-21 | 2002-06-06 | Kuslich Stephen D. | Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone |
US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
WO2002030487A2 (en) | 2000-10-11 | 2002-04-18 | Micro Thereapeutics, Inc. | Methods for treating aneurysms |
CA2431594A1 (en) | 2000-10-24 | 2002-09-12 | Martin Dieck | Device and methods for treating vascular malformations |
US6547804B2 (en) | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US6866677B2 (en) | 2001-04-03 | 2005-03-15 | Medtronic Ave, Inc. | Temporary intraluminal filter guidewire and methods of use |
US20020147496A1 (en) | 2001-04-06 | 2002-10-10 | Integrated Vascular Systems, Inc. | Apparatus for treating spinal discs |
US20020188314A1 (en) | 2001-06-07 | 2002-12-12 | Microvena Corporation | Radiopaque distal embolic protection device |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US20030181927A1 (en) | 2001-06-21 | 2003-09-25 | Wallace Michael P. | Aneurysm neck obstruction device |
US6964671B2 (en) | 2001-06-28 | 2005-11-15 | Cordis Neurovascular, Inc. | Method and apparatus for placing a medical agent into a vessel of the body |
US6572628B2 (en) | 2001-06-28 | 2003-06-03 | Cordis Neurovascular, Inc. | Method and apparatus for placing a medical agent into a vessel of the body |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20030028209A1 (en) | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US6802851B2 (en) | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6811560B2 (en) | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
JP4350515B2 (en) | 2001-11-09 | 2009-10-21 | ルビコン・メデイカル・インコーポレイテツド | Stent delivery device |
JP2003190175A (en) | 2001-11-15 | 2003-07-08 | Cordis Neurovascular Inc | Aneurysm neck cover for sealing aneurysm |
JP4429589B2 (en) | 2001-11-15 | 2010-03-10 | コーディス・ニューロバスキュラー・インコーポレイテッド | Aneurysm embolization device using an occluding member |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
DE60315425T2 (en) | 2002-03-05 | 2008-06-26 | Salviac Ltd. | SYSTEM FOR PROTECTION FROM EMBOLICS |
US6773448B2 (en) | 2002-03-08 | 2004-08-10 | Ev3 Inc. | Distal protection devices having controllable wire motion |
US20030176884A1 (en) | 2002-03-12 | 2003-09-18 | Marwane Berrada | Everted filter device |
WO2003077776A1 (en) | 2002-03-15 | 2003-09-25 | Nmt Medical, Inc. | Coupling system useful in placement of implants |
US7695488B2 (en) | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US6833003B2 (en) | 2002-06-24 | 2004-12-21 | Cordis Neurovascular | Expandable stent and delivery system |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
US8075585B2 (en) | 2002-08-29 | 2011-12-13 | Stryker Corporation | Device and method for treatment of a vascular defect |
US20040044391A1 (en) | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US7229454B2 (en) | 2003-01-07 | 2007-06-12 | Boston Scientific Scimed, Inc. | Occlusive cinching devices and methods of use |
US20040254594A1 (en) | 2003-01-24 | 2004-12-16 | Arthur Alfaro | Cardiac defect occlusion device |
US7744583B2 (en) | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US7001369B2 (en) | 2003-03-27 | 2006-02-21 | Scimed Life Systems, Inc. | Medical device |
TWI221091B (en) | 2003-04-18 | 2004-09-21 | A Spine Holding Group Corp | Spine filling device |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
AU2004241111B2 (en) | 2003-05-15 | 2010-05-27 | Dsm Ip Assets B.V | Manufacture and use of implantable reticulated elastomeric matrices |
US7093527B2 (en) | 2003-06-10 | 2006-08-22 | Surpass Medical Ltd. | Method and apparatus for making intraluminal implants and construction particularly useful in such method and apparatus |
US7309345B2 (en) | 2003-07-25 | 2007-12-18 | Boston Scientific-Scimed, Inc. | Method and system for delivering an implant utilizing a lumen reducing member |
US7735493B2 (en) | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
DE10338702B9 (en) | 2003-08-22 | 2007-04-26 | Occlutech Gmbh | Occlusioninstrument |
US7371228B2 (en) | 2003-09-19 | 2008-05-13 | Medtronic Vascular, Inc. | Delivery of therapeutics to treat aneurysms |
US7232461B2 (en) | 2003-10-29 | 2007-06-19 | Cordis Neurovascular, Inc. | Neck covering device for an aneurysm |
AU2004289362A1 (en) | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Intravascular devices and fibrosis-inducing agents |
US8231649B2 (en) | 2004-01-20 | 2012-07-31 | Boston Scientific Scimed, Inc. | Retrievable blood clot filter with retractable anchoring members |
JP2007519489A (en) | 2004-01-30 | 2007-07-19 | エヌエムティー メディカル, インコーポレイティッド | Welding system for closure of cardia |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
BE1016067A3 (en) | 2004-06-03 | 2006-02-07 | Frid Noureddine | Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT. |
US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
EP1827250B1 (en) | 2004-08-31 | 2018-05-16 | Cook Medical Technologies LLC | Device for treating an aneurysm |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US7244270B2 (en) | 2004-09-16 | 2007-07-17 | Evera Medical | Systems and devices for soft tissue augmentation |
US20070270902A1 (en) | 2004-09-17 | 2007-11-22 | Slazas Robert R | Thin Film Metallic Devices for Plugging Aneurysms or Vessels |
EP1788956B1 (en) | 2004-09-17 | 2011-11-09 | Codman & Shurtleff, Inc. | Vascular occlusion device with an embolic mesh ribbon |
WO2006034153A2 (en) | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Thin film metallic devices for plugging aneurysms or vessels |
EP1804719A2 (en) | 2004-09-22 | 2007-07-11 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
JP2008519613A (en) | 2004-11-09 | 2008-06-12 | ボストン サイエンティフィック リミテッド | Vascular occlusion device with composite shaped proximal portion and smaller diameter distal |
US20060106421A1 (en) | 2004-11-16 | 2006-05-18 | Clifford Teoh | Expansible neck bridge |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US9545300B2 (en) | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
US20060155367A1 (en) | 2005-01-07 | 2006-07-13 | Hines Richard A | Micro-pleated stent assembly |
US20060155323A1 (en) | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
WO2006078988A2 (en) | 2005-01-21 | 2006-07-27 | Loubert Suddaby | Aneurysm repair method and apparatus |
US8025668B2 (en) | 2005-04-28 | 2011-09-27 | C. R. Bard, Inc. | Medical device removal system |
US7377932B2 (en) | 2005-06-02 | 2008-05-27 | Cordis Neurovascular, Inc. | Embolic coil delivery system with mechanical release mechanism |
US7985238B2 (en) | 2005-06-02 | 2011-07-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
US9636115B2 (en) | 2005-06-14 | 2017-05-02 | Stryker Corporation | Vaso-occlusive delivery device with kink resistant, flexible distal end |
AU2006262447A1 (en) | 2005-06-20 | 2007-01-04 | Medtronic Ablation Frontiers Llc | Ablation catheter |
JP2009512515A (en) | 2005-10-19 | 2009-03-26 | パルサー バスキュラー インコーポレイテッド | Methods and systems for clipping within a vessel and repairing intraluminal and tissue defects. |
US8545530B2 (en) | 2005-10-19 | 2013-10-01 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
US8066036B2 (en) | 2005-11-17 | 2011-11-29 | Microvention, Inc. | Three-dimensional complex coil |
WO2007076480A2 (en) | 2005-12-23 | 2007-07-05 | Levy Elad I | Bifurcated aneurysm treatment arrangement |
US20070167876A1 (en) | 2006-01-17 | 2007-07-19 | Euteneuer Charles L | Occluding guidewire and methods |
US20070186933A1 (en) | 2006-01-17 | 2007-08-16 | Pulmonx | Systems and methods for delivering flow restrictive element to airway in lungs |
US7744652B2 (en) | 2006-01-23 | 2010-06-29 | Hesham Morsi | Aneurysm sealing device |
CN101049266B (en) | 2006-04-03 | 2010-11-17 | 孟坚 | Medical use obstruction appliance, and manufacturing method |
JP5171804B2 (en) | 2006-03-14 | 2013-03-27 | サーモピューティックス インコーポレイテッド | Aneurysm coil delivery system |
CN101431963A (en) | 2006-03-24 | 2009-05-13 | 比奥米瑞斯公司 | Self-expandable endovascular device for aneurysm occlusion |
US9757260B2 (en) | 2006-03-30 | 2017-09-12 | Medtronic Vascular, Inc. | Prosthesis with guide lumen |
US20070239206A1 (en) | 2006-03-31 | 2007-10-11 | Shelton Frederick E Iv | Suture with adhesive/sealant delivery mechanism |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
US20070288083A1 (en) | 2006-05-12 | 2007-12-13 | Hines Richard A | Exclusion Device and System For Delivery |
BRPI0711784B8 (en) | 2006-06-15 | 2021-06-22 | Microvention Inc | embolization device constructed of expandable polymer and its method of preparation |
US8062325B2 (en) | 2006-07-31 | 2011-11-22 | Codman & Shurtleff, Inc. | Implantable medical device detachment system and methods of using the same |
US20080097401A1 (en) | 2006-09-22 | 2008-04-24 | Trapp Benjamin M | Cerebral vasculature device |
DE102006050385A1 (en) | 2006-10-05 | 2008-04-10 | pfm Produkte für die Medizin AG | Implantable mechanism for use in human and/or animal body for e.g. closing atrium septum defect, has partial piece that is folded back on another partial piece from primary form into secondary form of carrying structure |
US20080103505A1 (en) | 2006-10-26 | 2008-05-01 | Hendrik Raoul Andre Fransen | Containment device for site-specific delivery of a therapeutic material and methods of use |
US8372114B2 (en) | 2006-11-13 | 2013-02-12 | Electroformed Stents, Inc. | Over-the-wire exclusion device and system for delivery |
EP2263605A1 (en) | 2006-11-20 | 2010-12-22 | SeptRx, Inc. | Device and method for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool |
WO2008074027A1 (en) | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
US11166703B2 (en) | 2007-01-23 | 2021-11-09 | Cvdevices, Llc | Devices, systems, and methods for atrial appendage occlusion using light cure |
ES2856081T3 (en) | 2007-04-16 | 2021-09-27 | Occlutech Holding Ag | Occlusor for the occlusion of an atrial appendage and its production procedure |
EP2444010B1 (en) | 2007-05-18 | 2017-03-01 | Stryker European Holdings I, LLC | Medical implant detachment systems |
JP2010527742A (en) | 2007-05-31 | 2010-08-19 | レックス メディカル リミテッド パートナーシップ | Left atrial appendage closure device |
WO2008151204A1 (en) | 2007-06-04 | 2008-12-11 | Sequent Medical Inc. | Methods and devices for treatment of vascular defects |
US8034061B2 (en) | 2007-07-12 | 2011-10-11 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US8361138B2 (en) | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US8500773B2 (en) | 2007-08-01 | 2013-08-06 | Boston Scientific Scimed, Inc. | Spring detach joint for delivering a detachable implantable device |
EP2324775B1 (en) | 2007-08-02 | 2012-06-20 | Occlutech Holding AG | Method of producing a medical implantable device |
US20090082803A1 (en) | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
US9414842B2 (en) | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
CA2709379C (en) | 2007-12-21 | 2016-08-16 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
US9259225B2 (en) | 2008-02-19 | 2016-02-16 | St. Jude Medical, Cardiology Division, Inc. | Medical devices for treating a target site and associated method |
US9138213B2 (en) | 2008-03-07 | 2015-09-22 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
JP4719757B2 (en) | 2008-03-19 | 2011-07-06 | シスメックス株式会社 | Biological component analyzer, reaction cartridge of biological component analyzer, and extraction cartridge of biological component analyzer |
US8974518B2 (en) | 2008-03-25 | 2015-03-10 | Medtronic Vascular, Inc. | Eversible branch stent-graft and deployment method |
DE102008015781B4 (en) | 2008-03-26 | 2011-09-29 | Malte Neuss | Device for sealing defects in the vascular system |
DK2265193T3 (en) | 2008-04-21 | 2012-01-23 | Nfocus Neuromedical Inc | Embolic devices with braided ball and delivery systems |
WO2009135082A1 (en) | 2008-04-30 | 2009-11-05 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US10716573B2 (en) * | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
JP2011519300A (en) | 2008-05-01 | 2011-07-07 | アニュクローズ エルエルシー | Aneurysm occlusion device |
EP2279023B1 (en) | 2008-05-02 | 2020-12-02 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US8454632B2 (en) | 2008-05-12 | 2013-06-04 | Xlumena, Inc. | Tissue anchor for securing tissue layers |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US9232992B2 (en) | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US9351715B2 (en) | 2008-07-24 | 2016-05-31 | St. Jude Medical, Cardiology Division, Inc. | Multi-layered medical device for treating a target site and associated method |
US8262692B2 (en) | 2008-09-05 | 2012-09-11 | Merlin Md Pte Ltd | Endovascular device |
US20100069948A1 (en) | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8992568B2 (en) | 2008-10-20 | 2015-03-31 | Neil Duggal | Systems and methods for cerebrospinal fluid repair |
US8523902B2 (en) | 2009-01-30 | 2013-09-03 | Kfx Medical Corporation | System and method for attaching soft tissue to bone |
CA2758509C (en) | 2009-04-15 | 2018-02-20 | Microvention, Inc. | Implant delivery system |
US8398671B2 (en) | 2009-04-16 | 2013-03-19 | Stryker Corporation | Electrical contact for occlusive device delivery system |
US20120071911A1 (en) | 2009-05-20 | 2012-03-22 | University Of Miami | Spherical helix embolic coils for the treatment of cerebral aneurysms |
US8758423B2 (en) | 2009-06-18 | 2014-06-24 | Graftcraft I Goteborg Ab | Device and method for treating ruptured aneurysms |
US20120010644A1 (en) | 2009-07-09 | 2012-01-12 | Sideris Eleftherios B | Method and apparatus for occluding a physiological opening |
EP2453940A2 (en) | 2009-07-13 | 2012-05-23 | Yissum Research Development Company of The Hebrew University of Jerusalem | Intraluminal polymeric devices for the treatment of aneurysms |
WO2011038017A1 (en) | 2009-09-22 | 2011-03-31 | Penumbra, Inc. | Manual actuation system for deployment of implant |
CA2778639A1 (en) | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
US20110202085A1 (en) | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
US9814562B2 (en) | 2009-11-09 | 2017-11-14 | Covidien Lp | Interference-relief type delivery detachment systems |
US8226657B2 (en) | 2009-11-10 | 2012-07-24 | Carefusion 207, Inc. | Systems and methods for vertebral or other bone structure height restoration and stabilization |
US8734458B2 (en) | 2009-12-07 | 2014-05-27 | Globus Medical, Inc. | Methods and apparatus for treating vertebral fractures |
DE102009058132B4 (en) | 2009-12-12 | 2014-07-24 | Bentley Surgical Gmbh | Cylindrical occluder for sealing hollow cylindrical body vessels |
CN102188300B (en) | 2010-03-02 | 2014-05-28 | 上海微创医疗器械(集团)有限公司 | Aneurismal surgical device |
WO2011130081A1 (en) | 2010-04-14 | 2011-10-20 | Microvention, Inc. | Implant delivery device |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
EP2387951B1 (en) | 2010-05-23 | 2012-12-26 | Occlutech Holding AG | Braided medical device and manufacturing method therefore |
DK2585125T3 (en) | 2010-06-25 | 2014-12-08 | Fort Wayne Metals Res Prod | Biodegradable composite wire for medical devices |
US8876878B2 (en) | 2010-07-23 | 2014-11-04 | Medtronic, Inc. | Attachment mechanism for stent release |
BR112013005429A2 (en) | 2010-09-06 | 2016-06-07 | Nonwotecc Medical Gmbh | "device for closing openings or cavities in blood vessels" |
US20130066357A1 (en) | 2010-09-10 | 2013-03-14 | Maria Aboytes | Devices and methods for the treatment of vascular defects |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
JP6087281B2 (en) | 2010-09-10 | 2017-03-01 | メディナ メディカル,インコーポレイテッド | Device and method for treating vascular abnormalities |
CN101933850B (en) | 2010-09-16 | 2012-07-18 | 先健科技(深圳)有限公司 | Stopper and manufacturing method thereof |
US8616040B2 (en) | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
DE102010053111B4 (en) | 2010-12-01 | 2012-10-25 | Acandis Gmbh & Co. Kg | Arrangement with a device for supplying a medical functional element |
KR20140004679A (en) | 2010-12-20 | 2014-01-13 | 마이크로벤션, 인코포레이티드 | Polymer stents and methods of manufacture |
US20120165732A1 (en) | 2010-12-23 | 2012-06-28 | Synthes Usa, Llc | Balloon catheter comprising a zero-profile tip |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
CA2824284C (en) | 2011-01-17 | 2020-10-27 | Novita Therapeutics, Llc | Ballstent device and methods of use |
US8647358B2 (en) | 2011-01-21 | 2014-02-11 | Obalon Therapeutics Inc. | Intragastric device |
DE102011011869A1 (en) | 2011-02-22 | 2012-08-23 | Phenox Gmbh | implant |
CA2828960A1 (en) | 2011-03-02 | 2012-09-07 | Joe Michael Eskridge | Endovascular closure system |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
US9486604B2 (en) | 2011-05-12 | 2016-11-08 | Medtronic, Inc. | Packaging and preparation tray for a delivery system |
WO2012158668A1 (en) | 2011-05-17 | 2012-11-22 | Stryker Corporation | Method of fabricating an implantable medical device that includes one or more thin film polymer support layers |
EP3741314B1 (en) | 2011-05-23 | 2022-12-21 | Covidien LP | Retrieval systems |
WO2012166467A1 (en) | 2011-05-27 | 2012-12-06 | Stryker Corporation | Assembly for percutaneously inserting an implantable medical device, steering the device to a target location and deploying the device |
DE102011102955B4 (en) | 2011-05-31 | 2018-05-03 | Acandis Gmbh & Co. Kg | Medical implant for arranging a hollow body, in particular an aneurysm, and method for producing a medical implant |
EP2713905B1 (en) | 2011-06-03 | 2022-03-16 | Pulsar Vascular, Inc. | Systems for enclosing an anatomical opening, including shock absorbing aneurysm devices |
US8764787B2 (en) | 2011-06-17 | 2014-07-01 | Aga Medical Corporation | Occlusion device and associated deployment method |
US20120330341A1 (en) | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
WO2013016618A2 (en) | 2011-07-27 | 2013-01-31 | The Cleveland Clinic Foundation | Apparatus, system, and method for treating a regurgitant heart valve |
US9198668B2 (en) | 2011-08-04 | 2015-12-01 | Cook Medical Technologies Llc | Cerebral aneurysm closure device |
US20130035665A1 (en) | 2011-08-05 | 2013-02-07 | W. L. Gore & Associates, Inc. | Polymer-Based Occlusion Devices, Systems and Methods |
EP2567663A1 (en) | 2011-09-09 | 2013-03-13 | Occlutech Holding AG | A collapsible medical closing device, a method and a medical system for delivering an object |
US8734500B2 (en) | 2011-09-27 | 2014-05-27 | DePuy Synthes Products, LLC | Distal detachment mechanisms for vascular devices |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
US8261648B1 (en) | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
BR112014016789A8 (en) * | 2012-01-06 | 2017-07-04 | Inceptus Medical LLC | expandable occlusion devices and methods of use |
CA3049059C (en) | 2012-01-17 | 2023-03-07 | Metactive Medical, Inc. | Expandable body device and method of use |
WO2013116860A1 (en) | 2012-02-02 | 2013-08-08 | Inceptus Medical LLC | Aneurysm graft devices and methods |
AU2013231845B2 (en) | 2012-03-16 | 2017-07-06 | Terumo Corporation | Stent and stent delivery device |
US9717421B2 (en) | 2012-03-26 | 2017-08-01 | Medtronic, Inc. | Implantable medical device delivery catheter with tether |
US9833625B2 (en) | 2012-03-26 | 2017-12-05 | Medtronic, Inc. | Implantable medical device delivery with inner and outer sheaths |
US9808255B2 (en) | 2012-03-30 | 2017-11-07 | DePuy Synthes Products, Inc. | Embolic coil detachment mechanism with flexible distal member, resistive electrical heating element and shape memory polymer element |
DE102012102844B4 (en) | 2012-04-02 | 2020-03-19 | Acandis Gmbh | Occlusion device for implantation within an aneurysm and arrangement with such an occlusion device |
US9242290B2 (en) | 2012-04-03 | 2016-01-26 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US20150133989A1 (en) | 2012-04-20 | 2015-05-14 | Inceptus Medical, Llc | Expandable occlusion devices and methods of use |
US9078659B2 (en) | 2012-04-23 | 2015-07-14 | Covidien Lp | Delivery system with hooks for resheathability |
US9700399B2 (en) | 2012-04-26 | 2017-07-11 | Medtronic Vascular, Inc. | Stopper to prevent graft material slippage in a closed web stent-graft |
US9549832B2 (en) | 2012-04-26 | 2017-01-24 | Medtronic Vascular, Inc. | Apparatus and methods for filling a drug eluting medical device via capillary action |
WO2013184595A1 (en) | 2012-06-04 | 2013-12-12 | Penumbra, Inc. | Aneurysm occlusion system and method |
US9149190B2 (en) | 2012-07-17 | 2015-10-06 | Stryker Corporation | Notification system of deviation from predefined conditions |
EP2882350B1 (en) | 2012-08-13 | 2019-09-25 | MicroVention, Inc. | Shaped removal device |
SG11201501184XA (en) | 2012-08-22 | 2015-05-28 | Phenox Gmbh | Implant |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
CA2887604C (en) | 2012-10-15 | 2021-05-18 | Microvention, Inc. | Liquid embolic compositions and uses thereof for treating vascular conditions |
US20140135811A1 (en) | 2012-11-13 | 2014-05-15 | Covidien Lp | Occlusive devices |
US10039536B2 (en) | 2012-11-16 | 2018-08-07 | W. L. Gore & Associates, Inc. | Implantable medical device deployment system |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
EP2928550B1 (en) | 2012-12-07 | 2023-06-07 | Medtronic, Inc. | Minimally invasive implantable neurostimulation system |
US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
US10716549B2 (en) | 2013-03-05 | 2020-07-21 | St. Jude Medical, Cardiology Division, Inc. | Medical device for treating a target site |
US10973523B2 (en) | 2013-03-08 | 2021-04-13 | Aga Medical Corporation | Medical device for treating a target site |
US9681861B2 (en) | 2013-03-11 | 2017-06-20 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed collapsible medical closure device |
US9539382B2 (en) | 2013-03-12 | 2017-01-10 | Medtronic, Inc. | Stepped catheters with flow restrictors and infusion systems using the same |
US9539011B2 (en) | 2013-03-14 | 2017-01-10 | Stryker Corporation | Vaso-occlusive device delivery system |
WO2014150824A1 (en) | 2013-03-14 | 2014-09-25 | Stryker Corporation | Vaso-occlusive device delivery system |
US9717502B2 (en) | 2013-03-14 | 2017-08-01 | Stryker Corporation | Vaso-occlusive device delivery system |
EP3620203A1 (en) * | 2013-03-15 | 2020-03-11 | Insera Therapeutics, Inc. | Vascular treatment devices |
WO2014151123A1 (en) | 2013-03-15 | 2014-09-25 | Microvention, Inc. | Multi-component obstruction removal system and method |
US9398966B2 (en) | 2013-03-15 | 2016-07-26 | Medtronic Vascular, Inc. | Welded stent and stent delivery system |
EP2967806B1 (en) | 2013-03-15 | 2017-12-06 | Microvention, Inc. | Embolic protection device |
CN105142545B (en) | 2013-03-15 | 2018-04-06 | 柯惠有限合伙公司 | Locking device |
ES2717678T3 (en) | 2013-04-22 | 2019-06-24 | Stryker European Holdings I Llc | Procedure for loading drugs onto implant surfaces coated with hydroxyapatite |
US9445928B2 (en) | 2013-05-30 | 2016-09-20 | Medtronic Vascular, Inc. | Delivery system having a single handed deployment handle for a retractable outer sheath |
DE102013106031B4 (en) | 2013-06-11 | 2015-07-02 | Acandis Gmbh & Co. Kg | Medical implant and system with such an implant |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
CA2918098A1 (en) * | 2013-08-20 | 2015-02-26 | Boston Scientific Scimed, Inc. | Braided hemostasis shaft for improved torsional response |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US9675782B2 (en) | 2013-10-10 | 2017-06-13 | Medtronic Vascular, Inc. | Catheter pull wire actuation mechanism |
US9955978B2 (en) | 2013-10-25 | 2018-05-01 | Medtronic Vascular, Inc. | Tissue compression device with multi-chamber bladder |
US9795400B2 (en) | 2013-11-13 | 2017-10-24 | Covidien Lp | Galvanically assisted attachment of medical devices to thrombus |
US9833604B2 (en) | 2013-12-20 | 2017-12-05 | Microvention, Inc. | Delivery adapter |
WO2015095806A2 (en) | 2013-12-20 | 2015-06-25 | Microvention, Inc. | Device delivery system |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
WO2015157181A1 (en) | 2014-04-08 | 2015-10-15 | Stryker Corporation | Implant delivery system |
WO2015160721A1 (en) | 2014-04-14 | 2015-10-22 | Sequent Medical Inc. | Devices for therapeutic vascular procedures |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
JP6571760B2 (en) | 2014-04-30 | 2019-09-04 | シーラス エンドバスキュラー リミテッド | Occlusion device |
WO2015167997A1 (en) | 2014-04-30 | 2015-11-05 | Stryker Corporation | Implant delivery system and method of use |
PL3142586T3 (en) | 2014-05-14 | 2021-05-31 | President And Fellows Of Harvard College | Catheter device for transmitting and reflecting light |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
WO2015184075A1 (en) | 2014-05-28 | 2015-12-03 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
CN105792879A (en) | 2014-06-04 | 2016-07-20 | 恩菲纽姆血管技术有限公司 | Low radial force vascular device and method of occlusion |
BR102014014407A2 (en) | 2014-06-12 | 2016-04-19 | Biocelere Agroindustrial Ltda | expression cassette to transform eukaryotic cell, genetically modified micro-organism with efficient xylose consumption, process for biofuel and biochemical production and biofuel and / or biochemical thus produced |
US8900304B1 (en) | 2014-06-17 | 2014-12-02 | Abdulrazzaq Alobaid | Kyphoplasty cement encapsulation balloon |
US9668898B2 (en) | 2014-07-24 | 2017-06-06 | Medtronic Vascular, Inc. | Stent delivery system having dynamic deployment and methods of manufacturing same |
US9770577B2 (en) | 2014-09-15 | 2017-09-26 | Medtronic Xomed, Inc. | Pressure relief for a catheter balloon device |
WO2016044647A2 (en) | 2014-09-17 | 2016-03-24 | Metactive Medical, Inc. | Expandable body device and method of use |
US9579484B2 (en) | 2014-09-19 | 2017-02-28 | Medtronic Vascular, Inc. | Sterile molded dispenser |
CN104605909A (en) | 2014-12-30 | 2015-05-13 | 先健科技(深圳)有限公司 | Plugging device, manufacturing method for plugging device and woven mesh pipe for manufacturing plugging device |
WO2016118420A1 (en) * | 2015-01-20 | 2016-07-28 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms and method for use |
US9692557B2 (en) | 2015-02-04 | 2017-06-27 | Stryker European Holdings I, Llc | Apparatus and methods for administering treatment within a bodily duct of a patient |
EP3261703A4 (en) | 2015-02-25 | 2018-10-24 | Galaxy Therapeutics, LLC | System for and method of treating aneurysms |
CN204683687U (en) | 2015-04-15 | 2015-10-07 | 中国人民解放军第二军医大学 | A kind of intracranial aneurysm neck reconstructing device |
CN104958087B (en) | 2015-07-28 | 2018-09-25 | 杭州诺茂医疗科技有限公司 | A kind of occluder for left auricle |
US10154905B2 (en) | 2015-08-07 | 2018-12-18 | Medtronic Vascular, Inc. | System and method for deflecting a delivery catheter |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
EP3334354B1 (en) | 2015-08-11 | 2021-03-03 | Terumo Corporation | System for implant delivery |
WO2017049312A1 (en) | 2015-09-18 | 2017-03-23 | Microvention, Inc. | Releasable delivery system |
EP4327786A3 (en) | 2015-09-18 | 2024-05-01 | Terumo Corporation | Pushable implant delivery system |
CN108348323B (en) | 2015-09-18 | 2021-11-16 | 微仙美国有限公司 | Implant retention, detachment and delivery system |
WO2017049212A1 (en) | 2015-09-18 | 2017-03-23 | Microvention, Inc. | Vessel prosthesis |
CN108024821B (en) | 2015-09-21 | 2020-10-30 | 斯瑞克公司 | Embolectomy device |
WO2017053271A1 (en) | 2015-09-21 | 2017-03-30 | Stryker Corporation | Embolectomy devices |
US10172632B2 (en) | 2015-09-22 | 2019-01-08 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a stabilization tube |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
US10327791B2 (en) | 2015-10-07 | 2019-06-25 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon |
WO2017062383A1 (en) | 2015-10-07 | 2017-04-13 | Stryker Corporation | Multiple barrel clot removal devices |
US10786302B2 (en) | 2015-10-09 | 2020-09-29 | Medtronic, Inc. | Method for closure and ablation of atrial appendage |
US10271873B2 (en) | 2015-10-26 | 2019-04-30 | Medtronic Vascular, Inc. | Sheathless guide catheter assembly |
US20170147765A1 (en) | 2015-11-19 | 2017-05-25 | Penumbra, Inc. | Systems and methods for treatment of stroke |
US10631946B2 (en) | 2015-11-30 | 2020-04-28 | Penumbra, Inc. | System for endoscopic intracranial procedures |
EP3386580B1 (en) | 2015-12-09 | 2023-11-01 | Medtronic Vascular Inc. | Catheter with a lumen shaped as an identification symbol |
US10500046B2 (en) | 2015-12-14 | 2019-12-10 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
US10159568B2 (en) | 2015-12-14 | 2018-12-25 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
CN114732470A (en) | 2015-12-30 | 2022-07-12 | 斯瑞克公司 | Embolization device and method of making same |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
US10070950B2 (en) | 2016-02-09 | 2018-09-11 | Medtronic Vascular, Inc. | Endoluminal prosthetic assemblies, and associated systems and methods for percutaneous repair of a vascular tissue defect |
CA3014315C (en) | 2016-02-10 | 2022-03-01 | Microvention, Inc. | Intravascular treatment site access |
CN109219407B (en) | 2016-02-10 | 2022-05-13 | 微仙美国有限公司 | Device for vascular occlusion |
US10188500B2 (en) | 2016-02-12 | 2019-01-29 | Medtronic Vascular, Inc. | Stent graft with external scaffolding and method |
CN108697423A (en) | 2016-02-16 | 2018-10-23 | 伊瑟拉医疗公司 | The part flow arrangement of suction unit and anchoring |
US10952739B2 (en) | 2016-03-11 | 2021-03-23 | Sequent Medical, Inc. | Systems and methods for delivery of stents and stent-like devices |
CN109069160B (en) | 2016-03-17 | 2022-05-17 | S·珍耶那曼 | Occlusion of anatomical structures |
EP3436124B1 (en) | 2016-03-31 | 2022-08-31 | Medtronic Vascular Inc. | Expandable introducer sheath having a steering mechanism |
US20170281331A1 (en) | 2016-03-31 | 2017-10-05 | Medtronic Vascular, Inc. | Endoluminal prosthetic devices having fluid-absorbable compositions for repair of a vascular tissue defect |
US10695542B2 (en) | 2016-04-04 | 2020-06-30 | Medtronic Vascular, Inc. | Drug coated balloon |
US10252024B2 (en) | 2016-04-05 | 2019-04-09 | Stryker Corporation | Medical devices and methods of manufacturing same |
US10441407B2 (en) | 2016-04-12 | 2019-10-15 | Medtronic Vascular, Inc. | Gutter filling stent-graft and method |
US9987122B2 (en) | 2016-04-13 | 2018-06-05 | Medtronic Vascular, Inc. | Iliac branch device and method |
US10010403B2 (en) | 2016-04-18 | 2018-07-03 | Medtronic Vascular, Inc. | Stent-graft prosthesis and method of manufacture |
US20170304097A1 (en) | 2016-04-21 | 2017-10-26 | Medtronic Vascular, Inc. | Stent-graft delivery system having an inner shaft component with a loading pad or covering on a distal segment thereof for stent retention |
US10940294B2 (en) | 2016-04-25 | 2021-03-09 | Medtronic Vascular, Inc. | Balloon catheter including a drug delivery sheath |
US10517711B2 (en) | 2016-04-25 | 2019-12-31 | Medtronic Vascular, Inc. | Dissection prosthesis system and method |
ES2809160T3 (en) | 2016-04-25 | 2021-03-03 | Stryker Corp | Inversion mechanical thrombectomy appliance |
US10028759B2 (en) | 2016-04-25 | 2018-07-24 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses and methods |
CN109310446B (en) | 2016-04-25 | 2021-08-27 | 斯瑞克公司 | Preloaded eversion retractor thrombectomy devices and methods |
US11147952B2 (en) | 2016-04-28 | 2021-10-19 | Medtronic Vascular, Inc. | Drug coated inflatable balloon having a thermal dependent release layer |
US10406011B2 (en) | 2016-04-28 | 2019-09-10 | Medtronic Vascular, Inc. | Implantable medical device delivery system |
US10191615B2 (en) | 2016-04-28 | 2019-01-29 | Medtronic Navigation, Inc. | Method and apparatus for image-based navigation |
US10292844B2 (en) | 2016-05-17 | 2019-05-21 | Medtronic Vascular, Inc. | Method for compressing a stented prosthesis |
JP6803929B2 (en) | 2016-06-01 | 2020-12-23 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Improved reinforced balloon catheter |
EP4094699A1 (en) | 2016-06-03 | 2022-11-30 | Stryker Corporation | Inverting thrombectomy apparatuses |
US20200000477A1 (en) | 2016-08-03 | 2020-01-02 | Henry Nita LLC | Embolization Plug |
US20190209178A1 (en) | 2016-09-14 | 2019-07-11 | Medinol Ltd. | Aneurysm closure device |
JP7139346B2 (en) | 2017-02-23 | 2022-09-20 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Aneurysm device and delivery system |
US20180303531A1 (en) | 2017-04-24 | 2018-10-25 | Baxter International Inc. | Single-handed applicator |
WO2018218210A1 (en) | 2017-05-25 | 2018-11-29 | Microvention, Inc. | Adhesive occlusion systems |
CN107374688A (en) | 2017-07-17 | 2017-11-24 | 湖南瑞康通科技发展有限公司 | Plugging device in a kind of tube chamber |
WO2019038293A1 (en) | 2017-08-21 | 2019-02-28 | Cerus Endovascular Limited | Occlusion device |
US10806462B2 (en) | 2017-12-21 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US10751065B2 (en) | 2017-12-22 | 2020-08-25 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10716574B2 (en) | 2017-12-22 | 2020-07-21 | DePuy Synthes Products, Inc. | Aneurysm device and delivery method |
US11103252B2 (en) * | 2018-01-23 | 2021-08-31 | Swaminathan Jayaraman | Device to treat vascular defect and method of making the same |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10806461B2 (en) | 2018-04-27 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube |
US11596412B2 (en) * | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) * | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
-
2019
- 2019-12-05 US US16/703,973 patent/US11602350B2/en active Active
-
2020
- 2020-11-20 JP JP2020193178A patent/JP2021087772A/en active Pending
- 2020-11-30 KR KR1020200164259A patent/KR20210070916A/en unknown
- 2020-12-04 EP EP20212016.8A patent/EP3831316A3/en not_active Withdrawn
- 2020-12-04 CN CN202011401173.6A patent/CN112914656A/en not_active Withdrawn
-
2022
- 2022-10-20 US US17/969,851 patent/US20230062395A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11602350B2 (en) | 2023-03-14 |
KR20210070916A (en) | 2021-06-15 |
EP3831316A3 (en) | 2021-10-13 |
CN112914656A (en) | 2021-06-08 |
JP2021087772A (en) | 2021-06-10 |
US20210169495A1 (en) | 2021-06-10 |
EP3831316A2 (en) | 2021-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11583282B2 (en) | Layered braided aneurysm treatment device | |
US11602350B2 (en) | Intrasaccular inverting braid with highly flexible fill material | |
US11376012B2 (en) | Devices, systems, and methods for treatment of vascular defects | |
CN108433769B (en) | Occlusion device | |
US11457926B2 (en) | Implant having an intrasaccular section and intravascular section | |
US11278292B2 (en) | Inverting braided aneurysm treatment system and method | |
US20220225997A1 (en) | Aneurysm treatment device | |
US11413046B2 (en) | Layered braided aneurysm treatment device | |
US11607226B2 (en) | Layered braided aneurysm treatment device with corrugations | |
US20200305885A1 (en) | Aneurysm treatment device | |
US20220087681A1 (en) | Inverting braided aneurysm implant with dome feature | |
EP3984473A1 (en) | Inverting braided aneurysm treatment system | |
US20220202425A1 (en) | Semispherical braided aneurysm treatment system and method | |
WO2023175451A1 (en) | Semispherical braided aneurysm treatment system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOROCHOW, LACEY;LORENZO, JUAN;XU, RUIJIAO;REEL/FRAME:061481/0316 Effective date: 20191114 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |